| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | P C. Costa | Q54963488 |
| P2093 | author name string | Costa P | |
| Sousa Lobo JM | |||
| P2860 | cites work | Analysis of data on the medicament release from ointments | Q30855386 |
| Evaluation and comparison of dissolution data derived from different modified release dosage forms: an alternative method. | Q31987737 | ||
| Drug release from wax matrices. I. Analysis of data with first-order kinetics and with the diffusion-controlled model | Q36567222 | ||
| Versatile kinetic-approach to analysis of dissolution data | Q36642715 | ||
| Effects of hardness on the disintegration time and the dissolution rate of uncoated caffeine tablets | Q40348472 | ||
| Influence of Shape Factors on Kinetics of Drug Release from Matrix Tablets I: Theoretical | Q44286696 | ||
| Controlled release of 3',5'-diester prodrugs of 5-fluoro-2'-deoxyuridine from poly-L-lactic acid microspheres | Q44316282 | ||
| Effect of drug (core) particle size on the dissolution of theophylline from microspheres made from low molecular weight cellulose acetate propionate | Q44776521 | ||
| Drug/polymer matrix swelling and dissolution | Q45142788 | ||
| Dissolution properties of praziquantel--PVP systems | Q46985265 | ||
| In vitro release modulation from crosslinked pellets for site-specific drug delivery to the gastrointestinal tract. I. Comparison of pH-responsive drug release and associated kinetics. | Q52214868 | ||
| Modeling of drug release from erodible tablets. | Q52286449 | ||
| Optima: a windows-based program for computer-aided optimization of controlled-release dosage forms. | Q52288570 | ||
| Bioequivalence | Q52418827 | ||
| Linearization of dissolution rate curves by the Weibull distribution. | Q52962323 | ||
| Influence of Shape Factors on Kinetics of Drug Release from Matrix Tablets II: Experimental | Q53699649 | ||
| Application of binary polymer system in drug release rate modulation. 2. Influence of formulation variables and hydrodynamic conditions on release kinetics. | Q53773977 | ||
| Rate of Release of Medicaments from Ointment Bases Containing Drugs in Suspension | Q63918425 | ||
| Dissolution of fludrocortisone from phospholipid coprecipitates | Q68227128 | ||
| Diffusion in porous materials above the percolation threshold | Q68595865 | ||
| Interpretation of Percent Dissolved-Time Plots Derived from In Vitro Testing of Conventional Tablets and Capsules | Q71231275 | ||
| Drug release from wax matrices. II. Application of a mixture theory to the suflanilamide--wax system | Q72029365 | ||
| Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms | Q72311916 | ||
| Physical interpretation of parameters in the Rosin-Rammler-Sperling-Weibull distribution for drug release from controlled release dosage forms | Q72432090 | ||
| Investigation of factors influencing release of solid drug dispersed in inert matrices. II. Quantitation of procedures | Q72922772 | ||
| Investigation of factors influencing release of solid drug dispersed in inert matrices. 3. Quantitative studies involving the polyethylene plastic matrix | Q72922774 | ||
| Investigation of factors influencing release of solid drug dispersed in inert matrices. IV. Some studies involving the polyvinyl chloride matrix | Q72922778 | ||
| Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets | Q73426658 | ||
| MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES | Q76639638 | ||
| Dissolution rate studies. II. Dissolution of particles under conditions of rapid agitation | Q79452313 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 123-133 | |
| P577 | publication date | 2001-05-01 | |
| P1433 | published in | European Journal of Pharmaceutical Sciences | Q5412738 |
| P1476 | title | Modeling and comparison of dissolution profiles | |
| P478 | volume | 13 |
| Q50145811 | "Nano-Ginseng" for Enhanced Cytotoxicity AGAINST Cancer Cells |
| Q41553399 | 3D Nanoporous Anodic Alumina Structures for Sustained Drug Release. |
| Q39095685 | 5-Florouracil-loaded poly(lactic acid)-poly(caprolactone) hybrid scaffold: potential chemotherapeutic implant |
| Q53767963 | A Combinatorial Statistical Design Approach to Optimize the Nanostructured Cubosomal Carrier System for Oral Delivery of Ubidecarenone for Management of Doxorubicin-Induced Cardiotoxicity: In Vitro-In Vivo Investigations. |
| Q64228221 | A General Framework for Assessing In vitro/In vivo Correlation as a Tool for Maximizing the Benefit-Risk Ratio of a Treatment Using a Convolution-Based Modeling Approach |
| Q53305176 | A Novel Approach for Analyzing the Dissolution Mechanism of Solid Dispersions. |
| Q64982422 | A Novel Desloratadine-Benzoic Acid Co-Amorphous Solid: Preparation, Characterization, and Stability Evaluation. |
| Q92259427 | A Novel Gel-Forming Solution Based on PEG-DSPE/Solutol HS 15 Mixed Micelles and Gellan Gum for Ophthalmic Delivery of Curcumin |
| Q37739106 | A Review of Disintegration Mechanisms and Measurement Techniques. |
| Q59521850 | A Semi-mechanistic Modeling Strategy to Link In Vitro and In Vivo Drug Release for Modified Release Formulations |
| Q64984641 | A Thixotropic Polyglycerol Sebacate-Based Supramolecular Hydrogel as an Injectable Drug Delivery Matrix. |
| Q41955827 | A biodegradable polymeric system for peptide-protein delivery assembled with porous microspheres and nanoparticles, using an adsorption/infiltration process. |
| Q90095206 | A comparison of models for the analysis of the kinetics of drug release from PLGA-based nanoparticles |
| Q41500341 | A comprehensive development strategy in buccal drug delivery |
| Q87724888 | A floating hydrogel system capable of generating CO2 bubbles to diminish urinary obstruction after intravesical instillation |
| Q38301288 | A gastro-resistant ovalbumin bi-layered mini-tablet-in-tablet system for the delivery of Lactobacillus acidophilus probiotic to simulated human intestinal and colon conditions |
| Q90477380 | A liposome/gelatin methacrylate nanocomposite hydrogel system for delivery of stromal cell-derived factor-1α and stimulation of cell migration |
| Q89910042 | A method of elevated temperatures coupled with magnetic stirring to predict real time release from long acting progesterone PLGA microspheres |
| Q41990221 | A model-dependent approach to correlate accelerated with real-time release from biodegradable microspheres |
| Q42001245 | A moldable putty containing silk fibroin yolk shell particles for improved hemostasis and bone repair |
| Q46379979 | A nonlinear mixed effects IVIVC model for multi-release drug delivery systems. |
| Q46663830 | A novel amphiphilic nano hydrogel using ketene based polyester with polyacrylamide for controlled drug delivery system. |
| Q41125280 | A novel multi-unit tablet for treating circadian rhythm diseases |
| Q46744688 | A novel once daily microparticulate dosage form comprising lansoprazole to prevent nocturnal acid breakthrough in the case of gastro-esophageal reflux disease: preparation, pharmacokinetic and pharmacodynamic evaluation |
| Q52870990 | A novel pH-responsive hydrogel-based on calcium alginate engineered by the previous formation of polyelectrolyte complexes (PECs) intended to vaginal administration. |
| Q53431702 | A novel three-layered tablet for extended release with various layer formulations and in vitro release profiles. |
| Q39021086 | A proposed food breakdown classification system to predict food behavior during gastric digestion |
| Q73706629 | A reappraisal of drug release laws using Monte Carlo simulations: the prevalence of the Weibull function |
| Q40027648 | A short term quality control tool for biodegradable microspheres. |
| Q36129913 | Accelerated in-vitro release testing methods for extended-release parenteral dosage forms |
| Q89681200 | Aceclofenac fast dispersible tablet formulations: Effect of different concentration levels of Avicel PH102 on the compactional, mechanical and drug release characteristics |
| Q42776074 | Aceclofenac topical dosage forms: in vitro and in vivo characterization |
| Q41990208 | Adsorption of meloxicam on porous calcium silicate: characterization and tablet formulation. |
| Q41989306 | Agglomerates containing pantoprazole microparticles: modulating the drug release. |
| Q58348789 | Al-promoted increase of surface area and adsorption capacity in ordered mesoporous silica materials with a cubic structure |
| Q42199787 | Albumin nanoparticles coated with polysorbate 80 as a novel drug carrier for the delivery of antiretroviral drug-Efavirenz |
| Q50618289 | Alendronate-Loaded Modified Drug Delivery Lipid Particles Intended for Improved Oral and Topical Administration. |
| Q91962307 | Alginate Oligosaccharides Affect Mechanical Properties and Antifungal Activity of Alginate Buccal Films with Posaconazole |
| Q90249744 | Alginate-Based Delivery Systems for Bevacizumab Local Therapy: In Vitro Structural Features and Release Properties |
| Q43287009 | Aminolevulinic acid-loaded Witepsol microparticles manufactured using a spray congealing procedure: implications for topical photodynamic therapy |
| Q55333272 | Aminopropyl groups of the functionalized Mobil Crystalline Material 41 as a carrier for controlled diclofenac sodium and piroxicam delivery. |
| Q93056459 | An Ex Vivo Evaluation of Moxifloxacin Nanostructured Lipid Carrier Enriched In Situ Gel for Transcorneal Permeation on Goat Cornea |
| Q36743407 | An Improvement of the Efficacy of Moxifloxacin HCl for the Treatment of Bacterial Keratitis by the Formulation of Ocular Mucoadhesive Microspheres |
| Q38876101 | An In Situ Gelling Drug Delivery System for Improved Recovery after Spinal Cord Injury. |
| Q55386075 | An LTB-entrapped protein in PLGA nanoparticles preserves against enterotoxin of enterotoxigenic Escherichia coli. |
| Q91992477 | An Optimized Surfactant-Based PEG-PLCL In Situ Gel Formulation For Enhanced Activity Of Rosuvastatin In Poloxamer-Induced Hyperlipidemic Rats |
| Q35089556 | An integrated microrobotic platform for on-demand, targeted therapeutic interventions. |
| Q31030017 | Analysis of dissolution data using modified versions of Noyes-Whitney equation and the Weibull function. |
| Q54223493 | Antibacterial, anti-inflammatory, and bone-regenerative dual-drug-loaded calcium phosphate nanocarriers-in vitro and in vivo studies. |
| Q38448902 | Application of Box-Behnken design in the preparation and optimization of fenofibrate-loaded self-microemulsifying drug delivery system (SMEDDS). |
| Q35163175 | Application of Design of Experiment and Simulation Methods to Liquid Chromatography Analysis of Topical HIV Microbicides Stampidine and HI443. |
| Q44940228 | Application of active layering and coating techniques in the development of a multiparticulate, controlled release dosage form of a high-dose, highly soluble drug. |
| Q46324439 | Application of freeze-drying technology in manufacturing orally disintegrating films. |
| Q58790299 | Application of quasi-emulsification and modified double emulsification techniques for formulation of tacrolimus microsponges |
| Q92652135 | Application of statistical design to evaluate critical process parameters and optimize formulation technique of polymeric nanoparticles |
| Q41582110 | Applied Concepts in PBPK Modeling: How to Build a PBPK/PD Model |
| Q37146176 | Applying the Taguchi design for optimized formulation of sustained release gliclazide chitosan beads: an in vitro/in vivo study |
| Q51687589 | Artemisinin-Polyvinylpyrrolidone Composites Prepared by Evaporative Precipitation of Nanosuspension for Dissolution Enhancement. |
| Q26741568 | Assessing the potential of mathematical modelling in designing drug-releasing orthopaedic implants |
| Q42592527 | Assessment of dissolution profile of marketed aceclofenac formulations |
| Q48873833 | Assessment of novel iloperidone- and idebenone-loaded nanostructured lipid carriers: brain targeting efficiency and neuroprotective potential |
| Q35007929 | Augmented cytotoxicity of hydroxycamptothecin-loaded nanoparticles in lung and colon cancer cells by chemosensitizing pharmaceutical excipients |
| Q91344981 | Automatic Dissolution Testing with High-Temporal Resolution for Both Immediate-Release and Fixed-Combination Drug Tablets |
| Q39064310 | Bicontinuous cubic liquid crystalline nanoparticles for oral delivery of Doxorubicin: implications on bioavailability, therapeutic efficacy, and cardiotoxicity. |
| Q42285581 | Bio-dis and the paddle dissolution apparatuses applied to the release characterization of ketoprofen from hypromellose matrices |
| Q38792037 | Bioadhesive Surfactant Systems for Methotrexate Skin Delivery. |
| Q50915260 | Bioavailability enhancement and pharmacokinetic profile of an anticancer drug ibrutinib by self-nanoemulsifying drug delivery system. |
| Q92979390 | Biocompatible and Antibacterial Nitric Oxide-Releasing Pluronic F-127/Chitosan Hydrogel for Topical Applications |
| Q38856423 | Biodegradable poly(vinyl alcohol)/polyoxalate electrospun nanofibers for hydrogen peroxide-triggered drug release |
| Q64250482 | Biopharmaceutical Development of a Bifonazole Multiple Emulsion for Enhanced Epidermal Delivery |
| Q46299663 | Biopolymeric mucoadhesive bilayer patch of pravastatin sodium for buccal delivery and treatment of patients with atherosclerosis |
| Q49834140 | Biphasic drug release from electrospun polyblend nanofibers for optimized local cancer treatment |
| Q37996117 | Bisphosphonate-based strategies for bone tissue engineering and orthopedic implants |
| Q51733153 | Brain Targeting of 1,9-Pyrazoloanthrone an c-Jun-N-terminal Kinase Inhibitor Using Liposomes for Effective Management of Parkinson's Disease. |
| Q47248889 | Brain targeted oral delivery of doxycycline hydrochloride encapsulated Tween 80 coated chitosan nanoparticles against ketamine induced psychosis: behavioral, biochemical, neurochemical and histological alterations in mice |
| Q49181990 | Brain- and brain tumor-penetrating disulfiram nanoparticles: Sequence of cytotoxic events and efficacy in human glioma cell lines and intracranial xenografts. |
| Q53604750 | Bumadizone calcium dihydrate microspheres compressed tablets for colon targeting: formulation, optimization and in vivo evaluation in rabbits. |
| Q40259854 | Calcium Alginate and Calcium Alginate-Chitosan Beads Containing Celecoxib Solubilized in a Self-Emulsifying Phase |
| Q43179848 | Calcium Alginate-Neusilin US2 Nanocomposite Microbeads for Oral Sustained Drug Delivery of Poor Water Soluble Drug Aceclofenac Sodium |
| Q58704123 | Calcium Chloride Modified Alginate Microparticles Formulated by the Spray Drying Process: A Strategy to Prolong the Release of Freely Soluble Drugs |
| Q64117067 | Cancer Cells Treated by Clusters of Copper Oxide Doped Calcium Silicate |
| Q43109675 | Cationic surfactants-modified natural zeolites: improvement of the excipients functionality. |
| Q35054113 | Cellulose, chitosan, and keratin composite materials. Controlled drug release |
| Q38026512 | Challenges with developing in vitro dissolution tests for orally inhaled products (OIPs). |
| Q40484999 | Characterisation and in vitro antimicrobial activity of biosynthetic silver-loaded bacterial cellulose hydrogels. |
| Q40087018 | Characterisation and in vitro antimicrobial potential of liposome encapsulated silver ions against Candida albicans |
| Q48153806 | Characterisation, in-vitro and in-vivo evaluation of valproic acid-loaded nanoemulsion for improved brain bioavailability |
| Q42197236 | Characterization and stability analysis of biopolymeric matrices designed for phage-controlled release. |
| Q46865430 | Characterization of 5-fluorouracil microspheres for colonic delivery |
| Q59009769 | Characterization of Ketoprofen/Methyl-β-Cyclodextrin Complexes Prepared Using Supercritical Carbon Dioxide |
| Q93149472 | Characterizing the pH-Dependent Release Kinetics of Food-Grade Spray Drying Encapsulated Iron Microcapsules for Food Fortification |
| Q47886606 | Chitosan Engineered PAMAM Dendrimers as Nanoconstructs for the Enhanced Anti-Cancer Potential and Improved In vivo Brain Pharmacokinetics of Temozolomide. |
| Q40991966 | Chitosan and β-Cyclodextrin-epichlorohydrin Polymer Composite Film as a Plant Healthcare Material for Carbendazim-Controlled Release to Protect Rape against Sclerotinia sclerotiorum (Lib.) de Bary |
| Q50870646 | Chitosan crosslinked microparticles with encapsulated polyphenols: Water sorption and release properties. |
| Q44938486 | Chitosan microparticles: influence of the gelation process on the release profile and oral bioavailability of albendazole, a class II compound |
| Q42927551 | Chitosan microspheres of aceclofenac: In vitro and in vivo evaluation |
| Q35138011 | Chitosan superporous hydrogel composite-based floating drug delivery system: A newer formulation approach |
| Q43690103 | Chitosan-based intragastric delivery of cefuroxime axetil: development and in-vitro evaluation of mucoadhesive approach. |
| Q48170626 | Cilostazol-Loaded Poly(ε-Caprolactone) Electrospun Drug Delivery System for Cardiovascular Applications |
| Q41000535 | Clotrimazole-cyclodextrin based approach for the management and treatment of Candidiasis - A formulation and chemistry-based evaluation |
| Q51706707 | Cocrystal habit engineering to improve drug dissolution and alter derived powder properties. |
| Q51172914 | Colon-specific delivery of mesalazine chitosan microspheres. |
| Q36291829 | Comparative In Vitro Dissolution of Two Commercially Available Er-Zhi-Wan Herbal Medicinal Products |
| Q34784522 | Comparative biophysical properties of tenofovir-loaded, thiolated and nonthiolated chitosan nanoparticles intended for HIV prevention |
| Q41991310 | Comparative evaluation of single and bilayered lamotrigine floating tablets |
| Q42059878 | Comparative in vitro and in vivo evaluation of three tablet formulations of amiodarone in healthy subjects. |
| Q43121388 | Comparative release profile of sustained release matrix tablets of verapamil HCl. |
| Q39165503 | Comparative study using spheres, rods and spindle-shaped nanoplatelets on dispersion stability, dissolution and toxicity of CuO nanomaterials |
| Q54973983 | Comparison between the dissolution profiles of nine meloxicam tablet brands commercially available in Buenos Aires, Argentina. |
| Q57136246 | Comparison of Pectin Layers for Nicotine Transdermal Patch Preparation |
| Q57650982 | Comparison of different silica microporous structures as drug delivery systems for in vitro models of solid tumors |
| Q41963089 | Comparison of dissolution profiles and serum concentrations of two lamotrigine tablet formulations |
| Q44414368 | Comparison of dissolution profiles of Ibuprofen pellets. |
| Q53628784 | Comparison of film-coated retarded release pellets manufactured by layering technique or by bed rotor pelletization. |
| Q45953248 | Comparison of low-shear and high-shear granulation processes: effect on implantable calcium phosphate granule properties. |
| Q51092396 | Comparison of novel granulated pellet-containing tablets and traditional pellet-containing tablets by artificial neural networks. |
| Q42205504 | Comparison of three dissolution apparatuses for testing calcium phosphate pellets used as ibuprofen delivery systems |
| Q42776225 | Composite poly(vinyl alcohol)/poly(vinyl acetate) electrospun nanofibrous mats as a novel wound dressing matrix for controlled release of drugs |
| Q41989834 | Compressed matrix core tablet as a quick/slow dual-component delivery system containing ibuprofen |
| Q43263844 | Compressed matrix dual-component vaginal drug delivery system containing metoclopramide hydrochloride |
| Q41987401 | Compression-Coated Tablet for Colon Targeting: Impact of Coating and Core Materials on Drug Release |
| Q50540582 | Computational Modeling of Polymeric Physicochemical Properties for Formulation Development of a Drug Containing Basic Functionality. |
| Q64071457 | Conductomeric Evaluation of the Release Kinetics of Active Substances from Pharmaceutical Preparations Containing Iron Ions |
| Q45978369 | Control of encapsulation efficiency in polymeric microparticle system of tolmetin. |
| Q50442842 | Controlled Electrostatic Self-Assembly of Ibuprofen-Cationic Dextran Nanoconjugates Prepared by low Energy Green Process - a Novel Delivery Tool for Poorly Soluble Drugs |
| Q41110266 | Controlled porosity solubility modulated osmotic pump tablets of gliclazide |
| Q53188200 | Controlled release from protein particles encapsulated by molecular layer deposition. |
| Q43196639 | Controlled release hydrophilic matrix tablet formulations of isoniazid: design and in vitro studies. |
| Q41989699 | Controlled release matrix tablets of zidovudine: effect of formulation variables on the in vitro drug release kinetics |
| Q44427361 | Controlled release metformin hydrochloride microspheres of ethyl cellulose prepared by different methods and study on the polymer affected parameters. |
| Q39313340 | Controlled release of 5-fluorouracil and progesterone from magnetic nanoaggregates |
| Q41988653 | Controlled release of oral tetrahydrocurcumin from a novel self-emulsifying floating drug delivery system (SEFDDS). |
| Q55206230 | Controlled release of organic-inorganic nanohybrid:cefadroxil intercalated Zn-Al-layered double hydroxide. |
| Q46851051 | Controlled release tamsulosin hydrochloride from alginate beads with waxy materials |
| Q34281406 | Controlled-release systemic delivery - a new concept in cancer chemoprevention |
| Q41140853 | Controlling Adult Stem Cell Behavior Using Nanodiamond-Reinforced Hydrogel: Implication in Bone Regeneration Therapy |
| Q38543392 | Controlling drug delivery from coronary stents: are we aiming for the right targets? |
| Q39167030 | Critical Material Attributes of Strip Films Loaded With Poorly Water-Soluble Drug Nanoparticles: II. Impact of Polymer Molecular Weight |
| Q41713132 | Critical material attributes (CMAs) of strip films loaded with poorly water-soluble drug nanoparticles: I. Impact of plasticizer on film properties and dissolution. |
| Q38896329 | Critical material attributes (CMAs) of strip films loaded with poorly water-soluble drug nanoparticles: III. Impact of drug nanoparticle loading |
| Q82605589 | Crosslinking of gelatin-based drug carriers by genipin induces changes in drug kinetic profiles in vitro |
| Q35295502 | Crystallographic textures and morphologies of solution cast Ibuprofen composite films at solid surfaces. |
| Q58920733 | Curcumin-loaded sterically stabilized nanodispersion based on non-ionic colloidal system induced by ultrasound and solvent diffusion-evaporation |
| Q43240311 | Cyclodextrin-crosslinked poly(acrylic acid): adhesion and controlled release of diflunisal and fluconazole from solid dosage forms. |
| Q59060927 | Cyclosporine A Loaded PLGA Nanoparticles for Dry Eye Disease:In VitroCharacterization Studies |
| Q64998055 | Cytotoxic Effect of Paclitaxel and Lapatinib Co-Delivered in Polylactide-co-Poly(ethylene glycol) Micelles on HER-2-Negative Breast Cancer Cells. |
| Q33550419 | DDSolver: an add-in program for modeling and comparison of drug dissolution profiles |
| Q64099951 | Dapivirine Bioadhesive Vaginal Tablets Based on Natural Polymers for the Prevention of Sexual Transmission of HIV |
| Q41345133 | Delivery of antibiotics from cementless titanium-alloy cubes may be a novel way to control postoperative infections |
| Q48033793 | Denatured Whey Protein Powder as a New Matrix Excipient: Design and Evaluation of Mucoadhesive Tablets for Sustained Drug Release Applications. |
| Q43419578 | Deproteinized natural rubber film forming polymeric solutions for nicotine transdermal delivery |
| Q36936716 | Design and Evaluation of Voriconazole Loaded Solid Lipid Nanoparticles for Ophthalmic Application |
| Q47351335 | Design and biological functionality of a novel hybrid Ti-6Al-4V/hydrogel system for reconstruction of bone defects. |
| Q35098278 | Design and development of intraocular polymeric implant systems for long-term controlled-release of clindamycin phosphate for toxoplasmic retinochoroiditis |
| Q41965205 | Design and evaluation of a novel matrix type multiple units as biphasic gastroretentive drug delivery systems |
| Q49582210 | Design and evaluation of dental films of PEGylated rosin derivatives containing sparfloxacin for periodontitis |
| Q42270727 | Design and evaluation of gastroretentive levofloxacin floating mini-tablets-in-capsule system for eradication of Helicobacter pylori |
| Q55415648 | Design and evaluation of matrix-based controlled release tablets of diclofenac sodium and chondroitin sulphate. |
| Q39823416 | Design and evaluation of niacin microspheres |
| Q51677548 | Design and evaluation of ocular drug delivery system for controlled delivery of gatifloxacin sesquehydrate: In vitro and in vivo evaluation. |
| Q42765254 | Design and evaluation of polyox and pluronic controlled gastroretentive delivery of troxipide |
| Q54633307 | Design and in vitro characterization of buccoadhesive tablets of timolol maleate. |
| Q39068952 | Design and in vitro evaluation of a novel controlled onset extended-release delivery system of metoprolol tartrate |
| Q41989792 | Design and study of lamivudine oral controlled release tablets |
| Q42651311 | Design of a novel bilayered gastric mucoadhesive system for localized and unidirectional release of lamotrigine |
| Q50219926 | Design of antihistaminic transdermal films based on alginate-chitosan polyelectrolyte complexes: characterization and permeation studies |
| Q42714978 | Design of bilayer tablets using modified Dioscorea starches as novel excipients for immediate and sustained release of aceclofenac sodium |
| Q47819532 | Design of composite microparticle systems based on pectin and waste material of propolis for modified l-alanyl-l-glutamine release and with immunostimulant activity |
| Q44523979 | Design of controlled release delivery systems using a modified pharmacokinetic approach: a case study for drugs having a short elimination half-life and a narrow therapeutic index |
| Q103827168 | Design of multicomponent indomethacin-paracetamol and famotidine loaded nanoparticles for sustained and effective anti-inflammatory therapy |
| Q41888180 | Design, Development and Optimization of S (-) Atenolol Floating Sustained Release Matrix Tablets Using Surface Response Methodology |
| Q42705880 | Design, Development, and Optimization of Dexibuprofen Microemulsion Based Transdermal Reservoir Patches for Controlled Drug Delivery |
| Q40335871 | Design, Development, and Optimization of Sterculia Gum-Based Tablet Coated with Chitosan/Eudragit RLPO Mixed Blend Polymers for Possible Colonic Drug Delivery |
| Q48014855 | Design, characterization and antimalarial efficacy of PEGylated galactosylated nano lipid carriers of primaquine phosphate |
| Q43718199 | Design, development and optimization of oral colon targeted drug delivery system of azathioprine using biodegradable polymers |
| Q55668717 | Design, development, and optimization of polymeric based-colonic drug delivery system of naproxen. |
| Q45920658 | Design, development, physicochemical, in vitro and in vivo evaluation of monolithic matrix type transdermal patches containing nitrendipine. |
| Q42824681 | Design, formulation and evaluation of green tea chewing gum. |
| Q94555885 | Designing Biodegradable Wafers Based on Poly(L-lactide-co-glycolide) and Poly(glycolide-co-ε-caprolactone) for the Prolonged and Local Release of Idarubicin for the Therapy of Glioblastoma Multiforme |
| Q47390440 | Developing a quality by design approach to model tablet dissolution testing: an industrial case study |
| Q91705523 | Development Of Saquinavir Mesylate Nanoemulsion-Loaded Transdermal Films: Two-Step Optimization Of Permeation Parameters, Characterization, And Ex Vivo And In Vivo Evaluation |
| Q92717688 | Development and Characterisation of Gastroretentive Solid Dosage Form Based on Melt Foaming |
| Q47594668 | Development and Characterization of Chitosan Cross-Linked With Tripolyphosphate as a Sustained Release Agent in Tablets, Part I: Design of Experiments and Optimization |
| Q42140781 | Development and Characterization of an Amorphous Solid Dispersion of Furosemide in the Form of a Sublingual Bioadhesive Film to Enhance Bioavailability. |
| Q93007811 | Development and In Vitro Evaluation of Lyotropic Liquid Crystals for the Controlled Release of Dexamethasone |
| Q50551221 | Development and In Vitro-In Vivo Characterization of Chronomodulated Pulsatile Delivery Formulation of Terbutaline Sulphate by Box-Behnken Statistical Design. |
| Q92723756 | Development and In Vitro-In Vivo Evaluation of a Novel Sustained-Release Loxoprofen Pellet with Double Coating Layer |
| Q46079358 | Development and biopharmaceutical evaluation of extended release formulation of tramadol hydrochloride based on osmotic technology |
| Q42532054 | Development and characterization of a new oral dapsone nanoemulsion system: permeability and in silico bioavailability studies |
| Q41848180 | Development and characterization of gastroretentive sustained-release formulation by combination of swelling and mucoadhesive approach: a mechanistic study |
| Q37538899 | Development and characterization of lyophilized diazepam-loaded polymeric micelles |
| Q53394635 | Development and characterization of novel site specific hollow floating microspheres bearing 5-Fu for stomach targeting. |
| Q48185685 | Development and characterization of solid dispersion-microsphere controlled release system for poorly water-soluble drug |
| Q40737596 | Development and dissolution studies of bisphosphonate (clodronate)-containing hydroxyapatite-polylactic acid biocomposites for slow drug delivery |
| Q42285793 | Development and evaluation of a floating multiparticulate gastroretentive system for modified release of AZT |
| Q82714400 | Development and evaluation of a pH-dependent sustained release tablet for irritable bowel syndrome |
| Q40301159 | Development and evaluation of aceclofenac-loaded mucoadhesive microcapsules |
| Q34926050 | Development and evaluation of controlled porosity osmotic pump for nifedipine and metoprolol combination |
| Q41988884 | Development and evaluation of hydrophilic colloid matrix of famotidine tablets. |
| Q43136193 | Development and evaluation of in situ gel of pregabalin |
| Q45954905 | Development and evaluation of ocular drug delivery system. |
| Q36882127 | Development and evaluation of sustained-release etoposide-loaded poly(ε-caprolactone) implants |
| Q50849792 | Development and experimental design of a novel controlled-release matrix tablet formulation for indapamide hemihydrate. |
| Q45770364 | Development and in vitro-in vivo evaluation of polymeric implants for continuous systemic delivery of curcumin |
| Q48653978 | Development and optimisation of mucoadhesive nanoparticles of acyclovir using design of experiments approach |
| Q47327071 | Development and optimization of locust bean gum and sodium alginate interpenetrating polymeric network of capecitabine |
| Q38743036 | Development and optimization of transferrin-conjugated nanostructured lipid carriers for brain delivery of paclitaxel using Box-Behnken design |
| Q42925017 | Development and oral bioavailability assessment of a supersaturated self-microemulsifying drug delivery system (SMEDDS) of albendazole |
| Q38816102 | Development and physicochemical characterization of acetalated dextran aerosol particle systems for deep lung delivery |
| Q37330760 | Development and statistical optimization of nefopam hydrochloride loaded nanospheres for neuropathic pain using Box-Behnken design |
| Q41988902 | Development and validation of a discriminating in vitro dissolution method for a poorly soluble drug, olmesartan medoxomil: comparison between commercial tablets. |
| Q42287179 | Development and validation of new discriminative dissolution method for carvedilol tablets |
| Q99557678 | Development of Bioadhesive Buccal Tablets of Nicorandil Using a Factorial Approach |
| Q97526255 | Development of Floating Tablets of Metformin HCl by Thermoplastic Granulation. Part II: In Vitro Evaluation of the Combined Effect of Acacia Gum/HPMC on Biopharmaceutical Performances |
| Q57149926 | Development of Graphene Oxide-/Galactitol Polyester-Based Biodegradable Composites for Biomedical Applications |
| Q57646901 | Development of In Situ Gelling Inserts by Lyophilization for Nasal Delivery of Terbutaline Sulfate |
| Q39153401 | Development of Intramammary Drug Delivery Systems: Novel In Vitro Release Method |
| Q89310113 | Development of Novel Delivery System for Cardiovascular Drug Molsidomine: Influence of Synthesis Method and Conditions on Molsidomine Release From Its Composites With Hydrophilic Silica In Vitro |
| Q29305365 | Development of Novel Oral Formulations Prepared via Hot Melt Extrusion for Targeted Delivery of Photosensitizer to the Colon |
| Q53538350 | Development of Novel Warfarin-Silica Composite for Controlled Drug Release. |
| Q50021401 | Development of Orally Applicable, Combinatorial Drug Loaded Nanoparticles for the Treatment of Fibrosarcoma |
| Q89510821 | Development of a Biodegradable Subcutaneous Implant for Prolonged Drug Delivery Using 3D Printing |
| Q89207828 | Development of a Clinically Relevant Dissolution Method for Metaxalone Immediate Release Formulations Based on an IVIVC Model |
| Q49562592 | Development of a new esomeprazole delayed release gastro-resistant pellet formulation with improved storage stability. |
| Q84356851 | Development of a new method to assess nanocrystal dissolution based on light scattering |
| Q57609716 | Development of a novel nanocomposite consisting of 3-(4-methoxyphenyl)propionic acid and magnesium layered hydroxide for controlled-release formulation |
| Q89724262 | Development of an Aerosol Dose Collection Apparatus for In Vitro Dissolution Measurements of Orally Inhaled Drug Products |
| Q36442138 | Development of bilayer floating tablet of amoxicillin and Aloe vera gel powder for treatment of gastric ulcers |
| Q39360068 | Development of bioadhesive chitosan superporous hydrogel composite particles based intestinal drug delivery system |
| Q47700116 | Development of extended-release solid dispersion granules of tacrolimus: evaluation of release mechanism and human oral bioavailability |
| Q44792283 | Development of intra-vaginal matrices from polycaprolactone for sustained release of antimicrobial agents |
| Q41043744 | Development of low density azithromycin-loaded polycaprolactone microparticles for pulmonary delivery |
| Q39641846 | Development of matrix type transdermal patches of lercanidipine hydrochloride: physicochemical and in-vitro characterization |
| Q41110484 | Development of modified-release tablets of zolpidem tartrate by biphasic quick/slow delivery system |
| Q41835088 | Development of oral sustained release rifampicin loaded chitosan nanoparticles by design of experiment |
| Q40216549 | Development of pH sensitive polymeric nanoparticles of erythromycin stearate |
| Q41903629 | Development of pH-sensitive insulin nanoparticles using Eudragit L100-55 and chitosan with different molecular weights. |
| Q33573494 | Development of satranidazole mucoadhesive gel for the treatment of periodontitis |
| Q48175399 | Development of solid dispersions of β-lapachone in PEG and PVP by solvent evaporation method |
| Q38920845 | Development of sulfadiazine-decorated PLGA nanoparticles loaded with 5-fluorouracil and cell viability. |
| Q56027225 | Diclofenac-loaded Eudragit S100 nanosuspension for ophthalmic delivery |
| Q90597161 | Different Types of Gel Carriers as Metronidazole Delivery Systems to the Oral Mucosa |
| Q64957182 | Different zeolite systems for colon cancer therapy: monitoring of ion release, cytotoxicity and drug release behavior. |
| Q28550326 | Diffusion Processes and Drug Release: Capsaicinoids - Loaded Poly (ε-caprolactone) Microparticles |
| Q44476298 | Direct, differential-equation-based in-vitro-in-vivo correlation (IVIVC) method |
| Q46925516 | Directly compressed mini matrix tablets containing ibuprofen: preparation and evaluation of sustained release |
| Q38548980 | Dissolution behavior of β-cyclodextrin molecular inclusion complexes of aceclofenac |
| Q38869541 | Dissolution comparisons using a Multivariate Statistical Distance (MSD) test and a comparison of various approaches for calculating the measurements of dissolution profile comparison |
| Q53259496 | Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers. |
| Q44822874 | Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin |
| Q41836027 | Dissolution enhancement of glibenclamide by solid dispersion: solvent evaporation versus a supercritical fluid-based solvent -antisolvent technique |
| Q36735320 | Dissolution of Intact, Divided and Crushed Circadin Tablets: Prolonged vs. Immediate Release of Melatonin |
| Q47930050 | Dissolution of anionic surfactant mesophases. |
| Q50800213 | Dissolution profiles of perindopril and indapamide in their fixed-dose formulations by a new HPLC method and different mathematical approaches. |
| Q43296465 | Dissolution rate and stability study of flavanone aglycones, naringenin and hesperetin, by drug delivery systems based on polyvinylpyrrolidone (PVP) nanodispersions. |
| Q44429201 | Dissolution rate enhancement of gliclazide by ordered mixing |
| Q58914159 | Drug Release Kinetics from Polymer Matrix through Fractal Approximation of Motion |
| Q92941288 | Drug Release Properties of Diflunisal from Layer-By-Layer Self-Assembled κ-Carrageenan/Chitosan Nanocapsules: Effect of Deposited Layers |
| Q48361465 | Drug Release as a function of bioactivity, incubation regime, liquid, and initial load: Release of bortezomib from calcium phosphate-containing silica/collagen xerogels |
| Q44589760 | Drug release kinetics and fronts movement studies from methyl methacrylate (MMA) copolymer matrix tablets: effect of copolymer type and matrix porosity. |
| Q37867128 | Drug release kinetics and physicochemical characteristics of floating drug delivery systems. |
| Q51911123 | Drug release kinetics from tablet matrices based upon ethylcellulose ether-derivatives: a comparison between different formulations. |
| Q48223372 | Drug self-assembly for synthesis of highly-loaded antimicrobial drug-silica particles. |
| Q39693592 | Drug targeting to macrophages using paromomycin-loaded albumin microspheres for treatment of visceral leishmaniasis: an in vitro evaluation. |
| Q47226870 | Drug transport mechanisms and in vitro release kinetics of vancomycin encapsulated chitosan-alginate polyelectrolyte microparticles as a controlled drug delivery system |
| Q98725956 | Drug-encapsulated blend of PLGA-PEG microspheres: in vitro and in vivo study of the effects of localized/targeted drug delivery on the treatment of triple-negative breast cancer |
| Q57346056 | Dual temperature- and pH-responsive ibuprofen delivery from poly(N-isopropylacrylamide-co-acrylic acid) nanoparticles and their fractal features |
| Q89907172 | Dual-Ligand Functionalized Core-Shell Chitosan-Based Nanocarrier for Hepatocellular Carcinoma-Targeted Drug Delivery |
| Q51548600 | Early development drug formulation on a chip: fabrication of nanoparticles using a microfluidic spray dryer. |
| Q91484213 | Effect of Different Tensoactives on the Morphology and Release Kinetics of PLA-b-PEG Microcapsules Loaded With the Natural Anticancer Compound Perillyl Alcohol |
| Q40891804 | Effect of Porosity on Strength Distribution of Microcrystalline Cellulose |
| Q36300177 | Effect of agar-gelatin compositions on the release of salbutamol tablets |
| Q33771106 | Effect of cations on the microstructure and in-vitro drug release of κ- and ι-carrageenan liquid and semi-solid aqueous dispersions |
| Q88716932 | Effect of formulation and process variables on lipid based sustained release tablets via continuous twin screw granulation: A comparative study |
| Q86954366 | Effect of gamma irradiation on drug releasing from nano-bioactive glass |
| Q55434724 | Effect of lipid and cellulose based matrix former on the release of highly soluble drug from extruded/spheronized, sintered and compacted pellets. |
| Q64984010 | Effect of natural curcuminoids-intercalated layered double hydroxide nanohybrid against Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus faecalis: A bactericidal, antibiofilm, and mechanistic study. |
| Q58598384 | Effect of over-encapsulation on the disintegration and dissolution of licensed formulations for blinding in randomised controlled trials |
| Q64911840 | Effect of permeation enhancers on in vitro release and transdermal delivery of lamotrigine from Eudragit®RS100 polymer matrix-type drug in adhesive patches. |
| Q49497957 | Effect of polymer type on characteristics of buccal tablets using factorial design |
| Q42774400 | Effect of production variables on the physicochemical characteristics of celecoxib-loaded stearic and alginic acids-based microparticles |
| Q51369715 | Effect of the drug-excipient ratio in matrix-type-controlled release systems: computer simulation study. |
| Q45065496 | Effect of zein on biodegradable inserts for the delivery of tetracycline within periodontal pockets. |
| Q58695685 | Effects of Compositional Tailoring on Drug Delivery Behaviours of Silica Xerogel/Polymer Core-shell Composite Nanoparticles |
| Q93373005 | Effects of formulation composition on the characteristics of mucoadhesive films prepared by hot-melt extrusion technology |
| Q41937463 | Effects of processing on the release profiles of matrix systems containing 5-aminosalicylic acid |
| Q53843332 | Effervescent tablet formulation for enhanced patient compliance and the therapeutic effect of risperidone. |
| Q43137669 | Efficacy and Physicochemical Evaluation of an Optimized Semisolid Formulation of Povidone Iodine Proposed by Extreme Vertices Statistical Design; a Practical Approach |
| Q57612144 | Efficient cutaneous wound healing using bixin-loaded PCL nanofibers in diabetic mice |
| Q90053412 | Electrosprayed polymeric nanobeads and nanofibers of modafinil: preparation, characterization, and drug release studies |
| Q92483543 | Encapsulation of Isoniazid-conjugated Phthalocyanine-In-Cyclodextrin-In-Liposomes Using Heating Method |
| Q45270103 | Encapsulation of actives for sustained release. |
| Q36032477 | Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion |
| Q61815669 | Enhanced Delivery of 4-Thioureidoiminomethylpyridinium Perchlorate in Tuberculosis Models with IgG Functionalized Poly(Lactic Acid)-Based Particles |
| Q91657541 | Enhanced Dissolution of Luteolin by Solid Dispersion Prepared by Different Methods: Physicochemical Characterization and Antioxidant Activity |
| Q91994928 | Enhanced Intradermal Delivery of Nanosuspensions of Antifilariasis Drugs Using Dissolving Microneedles: A Proof of Concept Study |
| Q57376963 | Enhanced mechanical stability and sensitive swelling performance of chitosan/yeast hybrid hydrogel beads |
| Q51087870 | Enhanced oral bioavailability of salmeterol by loaded PLGA microspheres: preparation, in vitro, and in vivo evaluation. |
| Q41913335 | Enhancement of dissolution rate of class II drugs (Hydrochlorothiazide); a comparative study of the two novel approaches; solid dispersion and liqui-solid techniques. |
| Q41989600 | Enhancement of dissolution rate of gliclazide using solid dispersions with polyethylene glycol 6000. |
| Q38622663 | Enhancement of ocular efficacy of aceclofenac using biodegradable PLGA nanoparticles: formulation and characterization |
| Q44027802 | Enhancement of solubility, dissolution release profile and reduction in ulcerogenicity of piroxicam by inclusion complex with skimmed milk |
| Q45260321 | Erosion characteristics of an erodible tablet incorporated in a time-delayed capsule device |
| Q50137838 | Eudragit S100 coated microsponges for Colon targeting of prednisolone |
| Q42717370 | Eudragit-based transdermal delivery system of pentazocine: Physico-chemical, in vitro and in vivo evaluations |
| Q59109894 | Evaluation of Chitosan Based Polymeric Matrices for Sustained Stomach Specific Delivery of Propranolol Hydrochloride |
| Q42581894 | Evaluation of Influence of Various Polymers on Dissolution and Phase Behavior of Carbamazepine-Succinic Acid Cocrystal in Matrix Tablets |
| Q41339281 | Evaluation of Matrix Tablets Based on Eudragit®E100/Carbopol®971P Combinations for Controlled Release and Improved Compaction Properties of Water Soluble Model Drug Paracetamol |
| Q41812384 | Evaluation of Mimosa pudica seed mucilage as sustained-release excipient |
| Q35761631 | Evaluation of acetylated moth bean starch as a carrier for controlled drug delivery |
| Q37098805 | Evaluation of chemically modified hydrophobic sago starch as a carrier for controlled drug delivery. |
| Q39923448 | Evaluation of drug release from coated pellets based on isomalt, sugar, and microcrystalline cellulose inert cores |
| Q43289088 | Evaluation of drug release kinetics and physico-chemical characteristics of metronidazole floating beads based on calcium silicate and gas-forming agents. |
| Q89909642 | Evaluation of gum mastic (Pistacia lentiscus) as a microencapsulating and matrix forming material for sustained drug release |
| Q47376987 | Evaluation of hydrophilic, hydrophobic and waxy matrix excipients for sustained release tablets of venlafaxine hydrochloride |
| Q44325548 | Evaluation of mathematical models describing drug release from estradiol transdermal systems |
| Q57350839 | Evaluation of mesoporous silicate nanoparticles for the sustained release of the anticancer drugs: 5-fluorouracil and 7-hydroxycoumarin |
| Q42280939 | Evaluation of microporous polycaprolactone matrices for controlled delivery of antiviral microbicides to the female genital tract. |
| Q39646408 | Evaluation of the DDSolver software applications |
| Q65002864 | Evaluation of the Release Kinetics of a Pharmacologically Active Substance from Model Intra-Articular Implants Replacing the Cruciate Ligaments of the Knee. |
| Q96353896 | Evaluation of the drug release kinetics in assembled modular systems based on the Dome Matrix technology |
| Q33760050 | Experimental and mathematical studies on the drug release properties of aspirin loaded chitosan nanoparticles. |
| Q49957833 | Experimental and molecular modeling approach to optimize suitable polymers for fabrication of stable fluticasone nanoparticles with enhanced dissolution and antimicrobial activity |
| Q93242223 | Exploratory studies in heat-assisted continuous twin-screw dry granulation: A novel alternative technique to conventional dry granulation |
| Q53184501 | Exploring the Phase Behavior of Monoolein/Oleic Acid/Water Systems for Enhanced Donezepil Administration for Alzheimer Disease Treatment. |
| Q37213292 | Extended release felodipine self-nanoemulsifying system. |
| Q36317887 | Extraction efficiency and implications for absolute quantitation of propranolol in mouse brain, liver and kidney tissue sections using droplet-based liquid microjunction surface sampling high-performance liquid chromatography/electrospray ionization |
| Q39810160 | Fabrication and evaluation of lipid nanoparticulates for ocular delivery of a COX-2 inhibitor |
| Q91271768 | Fabrication of Hierarchical Polymeric Thin Films by Spin Coating Toward Production of Amorphous Solid Dispersion for Buccal Drug Delivery System: Preparation, Characterization, and In Vitro Release Investigations |
| Q47371881 | Fabrication of Niclosamide loaded solid lipid nanoparticles: in vitro characterization and comparative in vivo evaluation |
| Q57349936 | Fabrication of chitosan–polyacrylic acid complexes as polymeric osmogents for swellable micro/nanoporous osmotic pumps |
| Q96124386 | Fabrication of mucoadhesive buccal films for local administration of ketoprofen and lidocaine hydrochloride by combining fused deposition modeling and inkjet printing |
| Q48002651 | Fabrication of β-cyclodextrin-mediated single bimolecular inclusion complex: characterization, molecular docking, in-vitro release and bioavailability studies for gefitinib and simvastatin conjugate. |
| Q33713924 | Fabrication, characterization and in vitro evaluation of silibinin nanoparticles: an attempt to enhance its oral bioavailability |
| Q46555341 | Facile development of nanocomplex-in-nanoparticles for enhanced loading and selective delivery of doxorubicin to brain. |
| Q36361579 | Factorial designed 5-fluorouracil-loaded microsponges and calcium pectinate beads plugged in hydroxypropyl methylcellulose capsules for colorectal cancer |
| Q90379348 | Factors Contributing to Drug Release From Enteric-Coated Omeprazole Capsules: An In Vitro and In Vivo Pharmacokinetic Study and IVIVC Evaluation in Beagle Dogs |
| Q91810796 | Films based on the biopolymer poly(3-hydroxybutyrate) as platforms for the controlled release of dexamethasone |
| Q64907686 | Finasteride nano-transferosomal gel formula for management of androgenetic alopecia: ex vivo investigational approach. |
| Q64116995 | First-Principles and Empirical Approaches to Predicting In Vitro Dissolution for Pharmaceutical Formulation and Process Development and for Product Release Testing |
| Q39190537 | Floating Hydrogel with Self-Generating Micro-Bubbles for Intravesical Instillation |
| Q43263835 | Floating drug delivery of a locally acting H2-antagonist: an approach using an in situ gelling liquid formulation |
| Q39422869 | Floating elementary osmotic pump tablet (FEOPT) for controlled delivery of diethylcarbamazine citrate: a water-soluble drug |
| Q41898386 | Floating osmotic drug delivery system of ranitidine hydrochloride: development and evaluation--a technical note |
| Q58292002 | Formulation Development and Evaluation of Sustained Release Bioadhesive Bilayered Buccal Tablets of Furosemide |
| Q57378113 | Formulation Development and Optimization of Floating Granules of Acyclovir by Melt Granulation Technique |
| Q41988702 | Formulation Development of Morphine Sulfate Sustained-Release Tablets and Its Bioequivalence Study in Healthy Thai Volunteers |
| Q60923143 | Formulation and Characterization of Native and Crosslinked Hyaluronic Acid Microspheres for Dermal Delivery of Sodium Ascorbyl Phosphate: A Comparative Study |
| Q35693217 | Formulation and Characterization of Pyrazinamide Polymeric Nanoparticles for Pulmonary Tuberculosis: Efficiency for Alveolar Macrophage Targeting. |
| Q42545689 | Formulation and Evaluation of Cephalexin Extended-release Matrix Tablets Using Hydroxy Propyl Methyl Cellulose as Rate-controlling Polymer. |
| Q34277128 | Formulation and In Vitro evaluation of pH sensitive oil entrapped polymeric blended gellan gum buoyant beads of clarithromycin. |
| Q42880674 | Formulation and In-vitro Evaluation of pH-Sensitive Oil Entrapped Polymeric Blend Amoxicillin Beads for the Eradication of Helicobacter pylori |
| Q46268397 | Formulation and characterization of a compacted multiparticulate system for modified release of water-soluble drugs--Part II theophylline and cimetidine. |
| Q91864974 | Formulation and characterization of chlorhexidine HCl nanoemulsion as a promising antibacterial root canal irrigant: in-vitro and ex-vivo studies |
| Q36918895 | Formulation and design of sustained release matrix tablets of metformin hydrochloride: Influence of hypromellose and polyacrylate polymers |
| Q51684103 | Formulation and development of orodispersible sustained release tablet of domperidone. |
| Q46619357 | Formulation and evaluation of Alendronate Sodium gel for the treatment of bone resorptive lesions in Periodontitis |
| Q35023317 | Formulation and evaluation of Bacillus coagulans-loaded hypromellose mucoadhesive microspheres |
| Q53253673 | Formulation and evaluation of a montelukast sodium orally disintegrating tablet with a similar dissolution profile as the marketed product. |
| Q41989248 | Formulation and evaluation of bioadhesive buccal drug delivery of tizanidine hydrochloride tablets |
| Q41997862 | Formulation and evaluation of buccal film of Ivabradine hydrochloride for the treatment of stable angina pectoris |
| Q40105496 | Formulation and evaluation of cephalexin extended release matrix tablets using 3 factorial design. |
| Q39225535 | Formulation and evaluation of controlled release ethylcellulose and polyethylene glycol microspheres containing metoprolol tartrate. |
| Q40585544 | Formulation and evaluation of controlled-release tablet of zolpidem tartrate by melt granulation technique |
| Q42125607 | Formulation and evaluation of fast dissolving tablet containing domperidone ternary solid dispersion |
| Q30582201 | Formulation and evaluation of flurbiprofen-loaded genipin cross-linked gelatin microspheres for intra-articular delivery |
| Q41760988 | Formulation and evaluation of gastroretentive drug delivery system of propranolol hydrochloride |
| Q43240341 | Formulation and evaluation of monolithic matrix polymer films for transdermal delivery of nitrendipine |
| Q43130344 | Formulation and evaluation of multiple tablets as a biphasic gastroretentive floating drug delivery system for fenoverine |
| Q42497446 | Formulation and evaluation of sustained release bioadhesive tablets of ofloxacin using 3(2) factorial design |
| Q42840186 | Formulation and evaluation of sustained release enteric-coated pellets of budesonide for intestinal delivery |
| Q35596471 | Formulation and in vitro characterization of cefpodoxime proxetil gastroretentive microballoons |
| Q46901828 | Formulation and in vitro evaluation of ethyl cellulose microspheres containing zidovudine |
| Q42181911 | Formulation and mathematical optimization of controlled release calcium alginate micro pellets of frusemide |
| Q35033387 | Formulation and optimization of itraconazole polymeric lipid hybrid nanoparticles (Lipomer) using Box Behnken design |
| Q35646236 | Formulation and optimization of mucoadhesive nanodrug delivery system of acyclovir |
| Q35796474 | Formulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and Box-Behnken design |
| Q79948506 | Formulation and pharmacodynamic evaluation of captopril sustained release microparticles |
| Q38654865 | Formulation and pharmacokinetics of multi-layered matrix tablets: Biphasic delivery of diclofenac |
| Q51736311 | Formulation design and development of matrix diffusion controlled transdermal drug delivery of glimepiride. |
| Q45032510 | Formulation development and stability studies of norfloxacin extended-release matrix tablets. |
| Q56034764 | Formulation of floating metronidazole microspheres using cassava starch (Manihot esculenta) as polymer |
| Q47332697 | Formulation of sitagliptin-loaded oral polymeric nano scaffold: process parameters evaluation and enhanced anti-diabetic performance |
| Q41989380 | Formulation of sustained-release dosage form of verapamil hydrochloride by solid dispersion technique using Eudragit RLPO or Kollidon SR. |
| Q43640093 | Formulation parameters and release mechanism of theophylline loaded ethyl cellulose microspheres: effect of different dual surfactant ratios |
| Q47098250 | Formulation, Characterization, and In Vitro Evaluation of Transdermal Patches for Inhibiting Crystallization of Mefenamic Acid |
| Q46272567 | Formulation, in vitro and in vivo evaluation of lidocaine HCl ocular inserts for topical ocular anesthesia |
| Q39410919 | Formulation, in vitro evaluation and kinetic analysis of chitosan-gelatin bilayer muco-adhesive buccal patches of insulin nanoparticles |
| Q33553580 | Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl |
| Q58762561 | Franz Diffusion Cell Approach for Pre-Formulation Characterisation of Ketoprofen Semi-Solid Dosage Forms |
| Q42104146 | Functional Performance of Chitosan/Carbopol 974P NF Matrices in Captopril Tablets. |
| Q47204328 | Functionalization of Cotton Fabrics with Polycaprolactone Nanoparticles for Transdermal Release of Melatonin |
| Q50209322 | Functionalization of electrospun poly(caprolactone) fibers for pH-controlled delivery of doxorubicin hydrochloride |
| Q39963069 | Furosemide-loaded Alginate Microspheres Prepared by Ionic Cross-linking Technique: Morphology and Release Characteristics |
| Q28818664 | Gastroretentive behavior of orally administered radiolabeled tamarind seed formulations in rabbits validated by gamma scintigraphy |
| Q41964132 | Gellan gum-based mucoadhesive microspheres of almotriptan for nasal administration: Formulation optimization using factorial design, characterization, and in vitro evaluation |
| Q39252342 | Glucose-bearing biodegradable poly(amino acid) and poly(amino acid)-poly(ester) conjugates for controlled payload release. |
| Q48327353 | Gold nanoparticles capped with benzalkonium chloride and poly (ethylene imine) for enhanced loading and skin permeability of 5-fluorouracil |
| Q86484124 | Gold nanorods mediated controlled release of doxorubicin: nano-needles for efficient drug delivery |
| Q90235761 | HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin |
| Q41690420 | Halloysite nanotubes as carriers of vancomycin in alginate-based wound dressing. |
| Q47984473 | Herbicide/Zn-Al-layered double hydroxide hybrid composite: synthesis and slow/controlled release properties |
| Q42498321 | High-efficiency loading and controlled release of highly water-soluble drug, pravastatin sodium by use of cross-linked β-cyclodextrin. |
| Q95262949 | Highlighting the impact of chitosan on the development of gastroretentive drug delivery systems |
| Q64060734 | Highly Soluble Drugs Directly Granulated by Water Dispersions of Insoluble Eudragit® Polymers as a Part of Hypromellose K100M Matrix Systems |
| Q44514826 | Highly stable and degradable multifunctional microgel for self-regulated insulin delivery under physiological conditions |
| Q36977318 | Hollow microporous organic capsules |
| Q43463739 | Hp-β-CD-voriconazole in situ gelling system for ocular drug delivery: in vitro, stability, and antifungal activities assessment |
| Q37601061 | Hyaluronidase-sensitive nanoparticle templates for triggered release of HIV/AIDS microbicide in vitro |
| Q37594408 | Hybrid Nanostructures Containing Sulfadiazine Modified Chitosan as Antimicrobial Drug Carriers |
| Q57378159 | Hydrogel-Based Controlled Release Formulations: Designing Considerations, Characterization Techniques and Applications |
| Q41904463 | Hydrogels composed of cyclodextrin inclusion complexes with PLGA-PEG-PLGA triblock copolymers as drug delivery systems. |
| Q91292067 | Hydrothermal Synthesize of HF-Free MIL-100(Fe) for Isoniazid-Drug Delivery |
| Q52934045 | Hyperbranched polymers as drug carriers: microencapsulation and release kinetics. |
| Q35892633 | Immobilization of collagen peptide on dialdehyde bacterial cellulose nanofibers via covalent bonds for tissue engineering and regeneration |
| Q61451245 | Impact of Gelatin Supplemented with Gum Arabic, Tween 20, and β-Cyclodextrin on the Microencapsulation of Turkish Oregano Extract |
| Q46897568 | Impact of microparticle formulation approaches on drug burst release: a level A IVIVC. |
| Q64251283 | Improved Morphine-Loaded Hydrogels for Wound-Related Pain Relief |
| Q45353676 | Improved oral bioavailability of fexofenadine hydrochloride using lipid surfactants: ex vivo, in situ and in vivo studies |
| Q50774170 | Improved percutaneous delivery of ketoprofen using combined application of nanocarriers and silicon microneedles. |
| Q51718754 | Improving the stability of chitosan-gelatin-based hydrogels for cell delivery using transglutaminase and controlled release of doxycycline. |
| Q50045758 | In Vitro Evaluation of Cocoa Pod Husk Pectin as a Carrier for Chronodelivery of Hydrocortisone Intended for Adrenal Insufficiency. |
| Q51599918 | In Vitro Release Kinetics and Transferrin Saturation Study of Intravenous Iron Sucrose Entrapped in Poly(ethylene glycol)-Assisted Silica Xerogel. |
| Q38762373 | In Vitro and In Vivo Modeling of Hydroxypropyl Methylcellulose (HPMC) Matrix Tablet Erosion Under Fasting and Postprandial Status |
| Q28550450 | In Vitro and Sensory Evaluation of Capsaicin-Loaded Nanoformulations |
| Q58118470 | In situ determination of dissolution kinetics of d-limonene in supercritical carbon dioxide by Raman spectroscopy |
| Q41982844 | In vitro and in vivo evaluation of chitosan buccal films of ondansetron hydrochloride |
| Q33573427 | In vitro and in vivo studies on chitosan beads of losartan Duolite AP143 complex, optimized by using statistical experimental design |
| Q64104771 | In vitro comparative quality assessment of different brands of norfloxacin tablets available in Jimma, Southwest Ethiopia |
| Q39266143 | In vitro pharmaceutical characterization and statistical optimization of a novel topically applied instantly-soluble solid eye drop matrix |
| Q33742784 | In vitro quality evaluation of leading brands of ciprofloxacin tablets available in Bangladesh |
| Q51562996 | In vitro release and In vivo biocompatibility studies of biomimetic multilayered alginate-chitosan/β-TCP scaffold for osteochondral tissue. |
| Q50518218 | In vitro release characteristics and cellular uptake of poly(D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotides. |
| Q33773063 | In vitro release kinetics and bioavailability of gastroretentive cinnarizine hydrochloride tablet |
| Q57165527 | In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures |
| Q36900229 | In vitro-in vivo correlation evaluation of generic alfuzosin modified release tablets |
| Q83348285 | In vivo bioequivalence and in vitro similarity factor (f2) for dissolution profile comparisons of extended release formulations: how and when do they match? |
| Q58854071 | In vivo treatment of experimental neurocysticercosis with praziquantel nanosuspensions—a metabolic approach |
| Q33767372 | In-situ freeze-drying - forming amorphous solids directly within capsules: An investigation of dissolution enhancement for a poorly soluble drug. |
| Q64935704 | In-vitro study of Ketoprofen Release from Synthesized Silica Aerogels (as Drug Carriers) and Evaluation of Mathematical Kinetic Release Models. |
| Q92945996 | Inclusion Complexes of Citronella Oil with β-Cyclodextrin for Controlled Release in Biofunctional Textiles |
| Q44767479 | Incorporation of calcium salts into xanthan gum matrices: hydration, erosion and drug release characteristics |
| Q43066597 | Incorporation of tocopherol acetate-containing particles in acrylic bone cement. |
| Q58723030 | Increased Oral Bioavailability of Resveratrol by Its Encapsulation in Casein Nanoparticles |
| Q38736325 | Increased cellular uptake of lauryl gallate loaded in superparamagnetic poly(methyl methacrylate) nanoparticles due to surface modification with folic acid |
| Q92854607 | Influence of Acetylated Annealed Starch on the Release of β-Escin from the Anionic and Non-Ionic Hydrophilic Gels |
| Q37678318 | Influence of Chitosan Swelling Behaviour on Controlled Release of Tenofovir from Mucoadhesive Vaginal Systems for Prevention of Sexual Transmission of HIV. |
| Q57380403 | Influence of Hydrophilic Polymers on theβFactor in Weibull Equation Applied to the Release Kinetics of a Biologically Active Complex ofAesculus hippocastanum |
| Q59124975 | Influence of Sodium Alginate on Hypoglycemic Activity of Metformin Hydrochloride in the Microspheres Obtained by the Spray Drying |
| Q43667343 | Influence of charge on encapsulation and release behavior of small molecules in self-assembled layer-by-layer microcapsules |
| Q46776168 | Influence of different polymers on crystallization tendency and dissolution behavior of cilnidipine in solid dispersions |
| Q38842789 | Influence of drug load on dissolution behavior of tablets containing a poorly water-soluble drug: estimation of the percolation threshold |
| Q33563604 | Influence of formulation factors on tablet formulations with liquid permeation enhancer using factorial design |
| Q40968052 | Influence of freeze-drying and γ-irradiation in preclinical studies of flurbiprofen polymeric nanoparticles for ocular delivery using d-(+)-trehalose and polyethylene glycol |
| Q41872555 | Influence of pH modifiers and HPMC viscosity grades on nicotine-magnesium aluminum silicate complex-loaded buccal matrix tablets |
| Q37066843 | Influence of plasticizers on the stability and release of a prodrug of Delta(9)-tetrahydrocannabinol incorporated in poly (ethylene oxide) matrices |
| Q44887337 | Influence of polymer blends on the characterization of gliclazide--encapsulated into poly (ε-caprolactone) microparticles |
| Q45953245 | Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets. |
| Q41896701 | Influence of some formulation variables on the optimization of pH-dependent, colon-targeted, sustained-release mesalamine microspheres |
| Q28258571 | Influence of splitting on dissolution properties of metoprolol tablets |
| Q33574182 | Influence of surface chemistry on cytotoxicity and cellular uptake of nanocapsules in breast cancer and phagocytic cells |
| Q44395635 | Influence of surfactants on the release behaviour and structural properties of sol-gel derived silica xerogels embedded with metronidazole. |
| Q41987499 | Influence of the Component Excipients on the Quality and Functionality of a Transdermal Film Formulation. |
| Q60216292 | Influence of the Surface Acidity of the Alumina on the Sustained Release of Ketoprofen |
| Q41275250 | Inhaled sildenafil nanocomposites: lung accumulation and pulmonary pharmacokinetics |
| Q39604949 | Integration of dissolution into physiologically-based pharmacokinetic models III: PK-Sim®. |
| Q59155898 | Intercalation of tetracycline into layered clay mineral material for drug delivery purposes |
| Q41578324 | Interpolyelectrolyte complexes of Eudragit® EPO with hypromellose acetate succinate and Eudragit® EPO with hypromellose phthalate as potential carriers for oral controlled drug delivery |
| Q51631401 | Intestinal Permeability of β-Lapachone and Its Cyclodextrin Complexes and Physical Mixtures. |
| Q49334799 | Intra Nasal In situ Gelling System of Lamotrigine Using Ion Activated Mucoadhesive Polymer |
| Q91511716 | Intramacrophage delivery of dual drug loaded nanoparticles for effective clearance of Mycobacterium tuberculosis |
| Q97421439 | Intranasal delivery of paeoniflorin nanocrystals for brain targeting |
| Q92420963 | Investigation of Dissolution Mechanism and Release Kinetics of Poorly Water-Soluble Tadalafil from Amorphous Solid Dispersions Prepared by Various Methods |
| Q42183317 | Investigation of PEGylated derivatives of rosin as sustained release film formers |
| Q90657068 | Investigation of a Microemulsion Containing Clotrimazole and Itraconazole for Transdermal Delivery for the Treatment of Sporotrichosis |
| Q39641785 | Investigation of formulation variables affecting the properties of lamotrigine nanosuspension using fractional factorial design. |
| Q42315486 | Investigation of the in vitro performance difference of drug-Soluplus® and drug-PEG 6000 dispersions when prepared using spray drying or lyophilization |
| Q41968953 | Investigations on agglomeration and haemocompatibility of vitamin E TPGS surface modified berberine chloride nanoparticles |
| Q41747928 | Ionically Crosslinked Chitosan Hydrogels for the Controlled Release of Antimicrobial Essential Oils and Metal Ions for Wound Management Applications |
| Q41987101 | Isothermal microcalorimetry as a quality by design tool to determine optimal blending sequences. |
| Q41889210 | Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models |
| Q36184240 | K88 Fimbrial Adhesin Targeting of Microspheres Containing Gentamicin Made with Albumin Glycated with Lactose |
| Q46232614 | Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization |
| Q50117704 | Layered Double Hydroxide-Based Functional Nanohybrids as Controlled Release Carriers of Pharmaceutically Active Ingredients |
| Q95854102 | Levocetirizine Dihydrochloride-Loaded Chitosan Nanoparticles: Formulation and In Vitro Evaluation |
| Q30799097 | Linear-dendrimer type methoxy-poly (ethylene glycol)-b-poly (ε-caprolactone) copolymer micelles for the delivery of curcumin |
| Q43167526 | Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies |
| Q38699643 | Lipid-based nanosystem of edaravone: development, optimization, characterization and in vitro/in vivo evaluation |
| Q90207508 | Lipidic Liquid Crystalline Cubic Phases and Magnetocubosomes as Methotrexate Carriers |
| Q42291896 | Lipids bearing extruded-spheronized pellets for extended release of poorly soluble antiemetic agent-Meclizine HCl. |
| Q93006112 | Liqui-Pellet: the Emerging Next-Generation Oral Dosage Form Which Stems from Liquisolid Concept in Combination with Pelletization Technology |
| Q39147076 | Localization of fluconazole in oral cavity by preferential coating of buccoadhesive tablet for treatment of oral thrush |
| Q50995809 | Long-term controlled release of PLGA microparticles containing antidepressant mirtazapine. |
| Q89927192 | Lornoxicam controlled release transdermal gel patch: Design, characterization and optimization using co-solvents as penetration enhancers |
| Q90269060 | Lyophilized Iron Oxide Nanoparticles Encapsulated in Amphotericin B: A Novel Targeted Nano Drug Delivery System for the Treatment of Systemic Fungal Infections |
| Q39087090 | Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations |
| Q51111901 | Magnetically Controlled Drug Release System through Magnetomechanical Actuation. |
| Q58781567 | Mangosteen pericarp extract embedded in electrospun PVP nanofiber mats: physicochemical properties and release mechanism of α-mangostin |
| Q41529926 | Marine structure derived calcium phosphate-polymer biocomposites for local antibiotic delivery. |
| Q41987613 | Masking the bitter taste of injectable lidocaine HCl formulation for dental procedures. |
| Q97536069 | Mathematical Modeling and Release Kinetics of Green Tea Polyphenols Released from Casein Nanoparticles |
| Q51644639 | Mathematical modeling of drug delivery from torus-shaped single-layer devices |
| Q41988214 | Matrix tablets: the effect of hydroxypropyl methylcellulose/anhydrous dibasic calcium phosphate ratio on the release rate of a water-soluble drug through the gastrointestinal tract I. In vitro tests |
| Q57746315 | Melt-blended halloysite nanotubes/wheat starch nanocomposites as drug delivery system |
| Q39189806 | Methotrexate-loaded glass ionomer cements for drug release in the skeleton: An examination of composition-property relationships |
| Q35157127 | Methoxy-modified kaolinite as a novel carrier for high-capacity loading and controlled-release of the herbicide amitrole |
| Q45754039 | Methylprednisolone acetate-Eudragit® RS100 electrospuns: Preparation and physicochemical characterization |
| Q59043401 | Meticulous Overview on the Controlled Release Fertilizers |
| Q48132164 | Micellar nano-carriers for the delivery of STAT3 dimerization inhibitors to melanoma. |
| Q93081531 | Microencapsulation Curcuminoids for Effective Delivery in Pharmaceutical Application |
| Q34185709 | Microencapsulation: A promising technique for controlled drug delivery |
| Q92494094 | Minocycline-loaded PLGA electrospun membrane prevents alveolar bone loss in experimental peridontitis |
| Q38928616 | Modeling the Time Course of the Tissue Responses to Intramuscular Long-acting Paliperidone Palmitate Nano-/Microcrystals and Polystyrene Microspheres in the Rat. |
| Q51158447 | Modified-release capsules containing sodium riboflavin 5'-phosphate. |
| Q57806985 | Modulation of Hypoxia-Induced Chemoresistance to Polymeric Micellar Cisplatin: The Effect of Ligand Modification of Micellar Carrier Versus Inhibition of the Mediators of Drug Resistance |
| Q48504572 | Monolithic LC method applied to fesoterodine fumarate low dose extended-release tablets: Dissolution and release kinetics |
| Q43709447 | Mucoadhesive nanoliposomal formulation for vaginal delivery of an antifungal |
| Q35024311 | Multifunction hexagonal liquid-crystal containing modified surface TiO2 nanoparticles and terpinen-4-ol for controlled release |
| Q39641463 | Multilayered membrane-controlled microcapsules for controlled delivery of isoniazid. |
| Q38836707 | Multiple response optimization of processing and formulation parameters of Eudragit RL/RS-based matrix tablets for sustained delivery of diclofenac. |
| Q38871242 | Multipronged, strategic delivery of paclitaxel-topotecan using engineered liposomes to ovarian cancer |
| Q90736278 | Nanoantioxidant-Based Silica Particles as Flavonoid Carrier for Drug Delivery Applications |
| Q48797990 | Nanodiamond-based injectable hydrogel for sustained growth factor release: Preparation, characterization and in vitro analysis |
| Q43247356 | Nanoemulsion containing dapsone for topical administration: a study of in vitro release and epidermal permeation |
| Q58648290 | Nanoencapsulation of Nimodipine in Novel Biocompatible Poly(propylene-co-butylene succinate) Aliphatic Copolyesters for Sustained Release |
| Q57815914 | Nanolayered composite with enhanced ultraviolet ray absorption properties from simultaneous intercalation of sunscreen molecules |
| Q46041573 | Nanoparticle coated submicron emulsions: sustained in-vitro release and improved dermal delivery of all-trans-retinol |
| Q48284169 | Nanoparticle mediated brain targeted delivery of gallic acid: in vivo behavioral and biochemical studies for improved antioxidant and antidepressant-like activity |
| Q30386106 | Nanoparticles Based on Chitosan as Carriers for the Combined Herbicides Imazapic and Imazapyr. |
| Q33800631 | Nanosizing of a poorly soluble drug: technique optimization, factorial analysis, and pharmacokinetic study in healthy human volunteers. |
| Q38798931 | Nanostructured DPA-MPC-DPA triblock copolymer gel for controlled drug release of ketoprofen and spironolactone. |
| Q39557319 | Nanostructured delivery system for zinc phthalocyanine: preparation, characterization, and phototoxicity study against human lung adenocarcinoma A549 cells |
| Q52893748 | Nanostructured lipid carriers loaded with simvastatin: effect of PEG/glycerides on characterization, stability, cellular uptake efficiency and in vitro cytotoxicity. |
| Q36037637 | Natural curcuminoids encapsulated in layered double hydroxides: a novel antimicrobial nanohybrid |
| Q50671665 | Nefopam hydrochloride loaded microspheres for post-operative pain management: synthesis, physicochemical characterization and in-vivo evaluation. |
| Q57809877 | Neuro-fuzzy modeling of ibuprofen-sustained release from tablets based on different cellulose derivatives |
| Q39321451 | New poly(ester-amide) copolymers modified with polyether (PEAE) for anticancer drug encapsulation. |
| Q39375439 | New sustained release of zidovudine matrix tablets - cytotoxicity toward Caco-2 cells. |
| Q52038684 | Non-linear mixed effects models for the evaluation of dissolution profiles. |
| Q58907096 | Nonlinearities in Drug Release Process from Polymeric Microparticles: Long-Time-Scale Behaviour |
| Q39225543 | Norfloxacin and metronidazole topical formulations for effective treatment of bacterial infections and burn wounds. |
| Q53460577 | Nose to brain microemulsion-based drug delivery system of rivastigmine: formulation and ex-vivo characterization. |
| Q59018330 | Novel Caffeic Acid Nanocarrier: Production, Characterization, and Release Modeling |
| Q60921199 | Novel Findings about Double-Loaded Curcumin-in-HPβcyclodextrin-in Liposomes: Effects on the Lipid Bilayer and Drug Release |
| Q92408483 | Novel Gliclazide Electrosprayed Nano-Solid Dispersions: Physicochemical Characterization and Dissolution Evaluation |
| Q92980281 | Novel PEG-Modified Hybrid PLGA-Vegetable Oils Nanostructured Carriers for Improving Performances of Indomethacin Delivery |
| Q42734609 | Novel application of MRI technique combined with flow-through cell dissolution apparatus as supportive discriminatory test for evaluation of controlled release formulations |
| Q33574120 | Novel lansoprazole-loaded nanoparticles for the treatment of gastric acid secretion-related ulcers: in vitro and in vivo pharmacokinetic pharmacodynamic evaluation. |
| Q44029387 | Novel metrics to compare dissolution profiles |
| Q38966954 | Novel resveratrol and 5-fluorouracil coencapsulated in PEGylated nanoliposomes improve chemotherapeutic efficacy of combination against head and neck squamous cell carcinoma |
| Q34119493 | Novel water-soluble polyurethane nanomicelles for cancer chemotherapy: physicochemical characterization and cellular activities |
| Q95852002 | Ocular Application of Dirithromycin Incorporated Polymeric Nanoparticles: an In Vitro Evaluation |
| Q58699584 | Ocular administration of acetazolamide microsponges in situ gel formulations |
| Q46084252 | On the estimate of the rate constant in the homogeneous dissolution model. |
| Q47771787 | On-Chip Preparation of Streptokinase Entrapped in Chitosan Nanoparticles Used in Thrombolytic Therapy Potentially |
| Q46277918 | Optimisation of chloroquine phosphate loaded nanostructured lipid carriers using Box-Behnken design and its antimalarial efficacy. |
| Q91730396 | Optimising the release rate of naproxen liqui-pellet: a new technology for emerging novel oral dosage form |
| Q64122614 | Optimization and Formulation of Fucoxanthin-Loaded Microsphere (F-LM) Using Response Surface Methodology (RSM) and Analysis of Its Fucoxanthin Release Profile |
| Q47424137 | Optimization of Dissolution Compartments in a Biorelevant Dissolution Apparatus Golem v2, Supported by Multivariate Analysis. |
| Q41978785 | Optimization of LDL targeted nanostructured lipid carriers of 5-FU by a full factorial design |
| Q46091421 | Optimization of PLGA nanoparticles formulation containing L-DOPA by applying the central composite design. |
| Q39025443 | Optimization of artemether-loaded NLC for intranasal delivery using central composite design |
| Q46343786 | Optimization of chitosan succinate and chitosan phthalate microspheres for oral delivery of insulin using response surface methodology |
| Q48580295 | Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy |
| Q34991067 | Optimization, characterisation and pharmacokinetic studies of mucoadhesive oral multiple unit systems of ornidazole |
| Q89910170 | Optimizing pH-sensitive and time-dependent polymer formula of colonic pH-responsive pellets to achieve precise drug release |
| Q53485705 | Oral naringenin nanocarriers: Fabrication, optimization, pharmacokinetic and chemotherapeutic efficacy assessments. |
| Q50876732 | Original research paper. Formulation and pharmaceutical development of quetiapine fumarate sustained release matrix tablets using a QbD approach. |
| Q92943954 | Overcoming the Limits of Flash Nanoprecipitation: Effective Loading of Hydrophilic Drug into Polymeric Nanoparticles with Controlled Structure |
| Q39423987 | Oxycellulose beads with drug exhibiting pH-dependent solubility |
| Q51018585 | PCL-forsterite nanocomposite fibrous membranes for controlled release of dexamethasone. |
| Q41790616 | PEGylated rosin derivatives: novel microencapsulating materials for sustained drug delivery |
| Q96127780 | PLGA nanoparticles loaded with Gallic acid- a constituent of Leea indica against Acanthamoeba triangularis |
| Q35673296 | PLGA nanoparticles loaded with etoposide and quercetin dihydrate individually: in vitro cell line study to ensure advantage of combination therapy |
| Q50587758 | PLGA-PEG-RA-based polymeric micelles for tumor targeted delivery of irinotecan. |
| Q38812689 | Packing Polymorphism of Dapivirine and Its Impact on the Performance of a Dapivirine-Releasing Silicone Elastomer Vaginal Ring. |
| Q42557080 | Paclitaxel loaded carrier based biodegradable polymeric implants: Preparation and in vitro characterization |
| Q51616664 | Parameters affecting drug release from inert matrices. 1: Monte Carlo simulation. |
| Q44592283 | Pathways of paracetamol absorption from layered excipient suppositories: artificial intelligence approach |
| Q46749881 | Performance of multilayered particles: influence of a thin cushioning layer |
| Q36802478 | Perspectives on the role of nanotechnology in bone tissue engineering |
| Q51126048 | Pharmacokinetic delivery and metabolizing rate of nicardipine incorporated in hydrophilic and hydrophobic cyclodextrins using two-compartment mathematical model. |
| Q34922985 | Pharmacokinetics of injectable, long-acting nevirapine for HIV prophylaxis in breastfeeding infants |
| Q38969224 | Phosphorylation of silk fibroins improves the cytocompatibility of silk fibroin derived materials: a platform for the production of tuneable material |
| Q91998978 | Physical Hydrogels of Oxidized Polysaccharides and Poly(Vinyl Alcohol) for Wound Dressing Applications |
| Q46115404 | Physicochemical modulation of skin barrier by microwave for transdermal drug delivery |
| Q41973412 | Physicochemical properties of solid dispersions of gliclazide in polyvinylpyrrolidone K90. |
| Q46496080 | Poly (epsilon-caprolactone) microparticles containing Levobunolol HCl prepared by a multiple emulsion (W/O/W) solvent evaporation technique: effects of some formulation parameters on microparticle characteristics |
| Q50616168 | Poly(ethylene glycol)-co-methacrylamide-co-acrylic acid based nanogels for delivery of doxorubicin. |
| Q39763082 | Poly(lactide-co-glycolide) nanocapsules containing benzocaine: influence of the composition of the oily nucleus on physico-chemical properties and anesthetic activity. |
| Q37976484 | Poly(methyl methacrylate) particulate carriers in drug delivery |
| Q39989472 | Polyester-based microparticles of different hydrophobicity: the patterns of lipophilic drug entrapment and release |
| Q57345496 | Polyethyleneimine-Polyoxometalate-Based Supramolecular Self-assembled pH-Responsive Hydrogels: Formulation and in vitro Evaluation |
| Q38955018 | Polymer assisted entrapment of netilmicin in PLGA nanoparticles for sustained antibacterial activity. |
| Q92074796 | Polymeric Electrospun Fibrous Dressings for Topical Co-delivery of Acyclovir and Omega-3 Fatty Acids |
| Q59016596 | Polymeric Nanosuspensions for Enhanced Dissolution of Water Insoluble Drugs |
| Q43145017 | Polymeric alginate nanoparticles containing the local anesthetic bupivacaine. |
| Q30387682 | Polymeric and Solid Lipid Nanoparticles for Sustained Release of Carbendazim and Tebuconazole in Agricultural Applications |
| Q37643083 | Polymeric films as a promising carrier for bioadhesive drug delivery: Development, characterization and optimization |
| Q38964639 | Polymeric nanoparticles containing diazepam: preparation, optimization, characterization, in-vitro drug release and release kinetic study |
| Q57340433 | Polymers and Biopolymers in Pharmaceutical Technology |
| Q42961302 | Polymethacrylate microparticles gel for topical drug delivery |
| Q64062996 | Polysaccharide Thin Solid Films for Analgesic Drug Delivery and Growth of Human Skin Cells |
| Q39915754 | Population in vitro-in vivo correlation model for pramipexole slow-release oral formulations |
| Q47444314 | Potential of Cationic-Polymeric Nanoparticles for Oral Delivery of Naringenin: In Vitro and In Vivo Investigations |
| Q37950958 | Potential scenarios for nanomaterial release and subsequent alteration in the environment. |
| Q45065170 | Predicting Pulmonary Pharmacokinetics from In Vitro Properties of Dry Powder Inhalers. |
| Q41110566 | Preformulation studies on solid self-emulsifying systems in powder form containing magnesium aluminometasilicate as porous carrier. |
| Q100697604 | Preformulation-assisted design and characterization of modified release gastroretentive floating extrudates towards improved bioavailability and minimized side effects of baclofen |
| Q90066893 | Preparation and Characterization of Poloxamer 407 Solid Dispersions as an Alternative Strategy to Improve Benznidazole Bioperformance |
| Q41831312 | Preparation and Characterization of Salbutamol Sulphate Loaded Ethyl Cellulose Microspheres using Water-in-Oil-Oil Emulsion Technique |
| Q39384296 | Preparation and In Vitro Evaluation of a Stomach Specific Drug Delivery System based on Superporous Hydrogel Composite |
| Q57343786 | Preparation and characterization of a novel pH-sensitive coated microsphere for duodenum-specific drug delivery |
| Q47987073 | Preparation and characterization of alginate/chitosan formulations for ciprofloxacin-controlled delivery |
| Q42411627 | Preparation and characterization of cefuroxime axetil solid dispersions using hydrophilic carriers |
| Q41870210 | Preparation and characterization of celecoxib dispersions in soluplus(®): comparison of spray drying and conventional methods |
| Q47364783 | Preparation and characterization of dipyridamole solid dispersions for stabilization of supersaturation: effect of precipitation inhibitors type and molecular weight |
| Q41988584 | Preparation and characterization of nicotine-magnesium aluminum silicate complex-loaded sodium alginate matrix tablets for buccal delivery |
| Q33474505 | Preparation and characterization of spray-dried mucoadhesive microspheres of aceclofenac |
| Q42581352 | Preparation and characterization of superporous hydrogels as gastroretentive drug delivery system for rosiglitazone maleate |
| Q39138715 | Preparation and characterization of Δ(9)-tetrahydrocannabinol-loaded biodegradable polymeric microparticles and their antitumoral efficacy on cancer cell lines |
| Q89909577 | Preparation and evaluation of duloxetine hydrochloride enteric-coated pellets with different enteric polymers |
| Q40727561 | Preparation and evaluation of enteric-coated delayed-release pellets of duloxetine hydrochloride using a fluidized bed coater |
| Q35143230 | Preparation and evaluation of lidocaine hydrochloride in cyclodextrin inclusion complexes for development of stable gel in association with chlorhexidine gluconate for urogenital use |
| Q51701301 | Preparation and evaluation of novel metronidazole sustained release and floating matrix tablets. |
| Q82331574 | Preparation and evaluation of solid lipid nanoparticles of baicalin for ocular drug delivery system in vitro and in vivo |
| Q41334283 | Preparation and evaluation of transdermal plasters containing norfloxacin: a novel treatment for burn wound healing |
| Q42406155 | Preparation and in vitro characterization of mucoadhesive hydroxypropyl guar microspheres containing amlodipine besylate for nasal administration |
| Q45973123 | Preparation and in vitro characterization of piroxicam enteric coated pellets using powder layering technique. |
| Q57921065 | Preparation and in vitro characterization of poly(sebacic acid-co-ricinoleic acid)-based tamoxifen citrate-loaded microparticles for breast cancer |
| Q43519673 | Preparation and in vitro evaluation of etoposide-loaded PLGA microspheres for pulmonary drug delivery |
| Q41406355 | Preparation and in vitro evaluation of guar gum based triple-layer matrix tablet of diclofenac sodium. |
| Q41321186 | Preparation and in vitro/in vivo evaluation of antimicrobial ocular in situ gels containing a disappearing preservative for topical treatment of bacterial conjunctivitis |
| Q53393428 | Preparation and in vivo evaluation of spray dried matrix type controlled-release microparticles of tamsulosin hydrochloride for orally disintegrating tablet. |
| Q57283322 | Preparation and investigation of mefenamic acid – polyethylene glycol – sucrose ester solid dispersions |
| Q57382914 | Preparation of Colon-Targeted Acetylharpagide Tablets and its Release Properties and |
| Q34785682 | Preparation of Spray-Dried Soy Isoflavone-Loaded Gelatin Microspheres for Enhancement of Dissolution: Formulation, Characterization and in Vitro Evaluation |
| Q49723018 | Preparation of TPP-crosslinked chitosan microparticles by spray drying for the controlled delivery of progesterone intended for estrus synchronization in cattle. |
| Q41989589 | Preparation of a matrix type multiple-unit gastro retentive floating drug delivery system for captopril based on gas formation technique: in vitro evaluation. |
| Q33580634 | Preparation of lung-targeting, emodin-loaded polylactic acid microspheres and their properties |
| Q87268523 | Preparation of solid lipid nanoparticles as drug carriers for levothyroxine sodium with in vitro drug delivery kinetic characterization |
| Q39015939 | Preparation of vincristine sulfate-loaded poly (butylcyanoacrylate) nanoparticles modified with pluronic F127 and evaluation of their lymphatic tissue targeting |
| Q47566239 | Preparation, Characterization, and In Vivo Pharmacoscintigraphy Evaluation of an Intestinal Release Delivery System of Prussian Blue for Decorporation of Cesium and Thallium |
| Q40389214 | Preparation, Evaluation and Optimization of Multiparticulate System of Mebendazole for Colon Targeted Drug Delivery by Using Natural Polysaccharides |
| Q43216548 | Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration |
| Q42658196 | Process, Physicochemical Characterization and In-Vitro Assessment of Albendazole Microcrystals. |
| Q92632871 | Production and Characterization of Chitosan-Polyanion Nanoparticles by Polyelectrolyte Complexation Assisted by High-Intensity Sonication for the Modified Release of Methotrexate |
| Q91816526 | Production and Characterization of Glutathione-Chitosan Conjugate Films as Systems for Localized Release of Methotrexate |
| Q33738339 | Propolis varnish: antimicrobial properties against cariogenic bacteria, cytotoxicity, and sustained-release profile |
| Q33809771 | Push-pull osmotic pump for zero order delivery of lithium carbonate: development and in vitro characterization |
| Q41195492 | Pyrimethamine nanosuspension with improved bioavailability: in vivo pharmacokinetic studies |
| Q53540824 | QbD-enabled systematic development of gastroretentive multiple-unit microballoons of itopride hydrochloride. |
| Q33850443 | Quality Attributes and In Vitro Bioequivalence of Different Brands of Amoxicillin Trihydrate Tablets. |
| Q92722818 | Quality by Design Approach for Development and Characterisation of Solid Lipid Nanoparticles of Quetiapine Fumarate |
| Q57925136 | Quality by Design Approach for Development of W/O Type Microemulsion-Based Transdermal Systems for Atenolol |
| Q46577113 | Quality by design approach to understand the process of optimization of iloperidone nanostructured lipid carriers for oral bioavailability enhancement |
| Q90195148 | Rational Development of Liposomal Hydrogels: A Strategy for Topical Vaginal Antiretroviral Drug Delivery in the Context of HIV Prevention |
| Q38729768 | Real-Time Analysis of Tenofovir Release Kinetics Using Quantitative Phosphorus (31P) Nuclear Magnetic Resonance Spectroscopy. |
| Q38717509 | Recent advances in testing of microsphere drug delivery systems |
| Q51267553 | Reduced Burst Release and Enhanced Oral Bioavailability in Shikimic Acid-Loaded Polylactic Acid Submicron Particles by Coaxial Electrospray. |
| Q38885341 | Rehydrated sterically stabilized phospholipid nanomicelles of budesonide for nebulization: physicochemical characterization and in vitro, in vivo evaluations |
| Q42135259 | Relationship between Surface Properties and In Vitro Drug Release from Compressed Matrix Containing Polymeric Materials with Different Hydrophobicity Degrees. |
| Q41202008 | Relationship between Surface Properties and In Vitro Drug Release from a Compressed Matrix Containing an Amphiphilic Polymer Material |
| Q46636977 | Relationship between the solution thermodynamic properties of naproxen in organic solvents and its release profiles from PLGA microspheres. |
| Q57380840 | Release behavior and kinetic evaluation of formaldehyde from cotton clothing fabrics finished with DMDHEU-based durable press agents in water and synthetic sweat solution |
| Q35602780 | Release kinetics of paclitaxel and cisplatin from two and three layered gold nanoparticles |
| Q41827095 | Release kinetics of papaverine hydrochloride from tablets with different excipients. |
| Q53084299 | Release of selected amino acids from zinc carriers. |
| Q44541514 | Release profiles of theophylline from microspheres consisting of dextran derivatives and cellulose acetate butyrate: effect of polyion complex formation |
| Q40516900 | Repaglinide-loaded solid lipid nanoparticles: effect of using different surfactants/stabilizers on physicochemical properties of nanoparticles. |
| Q57347340 | Rheological characterization of multi-component hydrogel based on carboxymethyl cellulose: insight into its encapsulation capacity and release kinetics towards ibuprofen |
| Q51750668 | Rice bran and raspberry seed oil-based nanocarriers with self-antioxidative properties as safe photoprotective formulations. |
| Q43882895 | Rifampicin-loaded 'flower-like' polymeric micelles for enhanced oral bioavailability in an extemporaneous liquid fixed-dose combination with isoniazid |
| Q50593909 | Risk assessment for extending the Biopharmaceutics Classification System-based biowaiver of immediate release dosage forms of fluconazole in adults to the paediatric population. |
| Q53051724 | Risk-based approach for systematic development of gastroretentive drug delivery system. |
| Q79185362 | Role of heterogeneity in deterministic models of drug dissolution and their statistical characteristics |
| Q48275051 | SLN approach for nose-to-brain delivery of alprazolam |
| Q39287683 | Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy |
| Q40148926 | Screening of ionically crosslinked chitosan-tripolyphosphate microspheres using Plackett-Burman factorial design for the treatment of intrapocket infections |
| Q46058098 | Selection of the most suitable dissolution method for an extended release formulation based on IVIVC level A obtained on cynomolgus monkey |
| Q53131462 | Self-Assembled Thermoresponsive Nanogels Prepared by Reverse Micelle → Positive Micelle Method for Ophthalmic Delivery of Muscone, a Poorly Water-Soluble Drug. |
| Q45165954 | Self-assembled carbohydrate hydrogels for prolonged pain management |
| Q55686117 | Self-nanomicellizing solid dispersion of edaravone: part I – oral bioavailability improvement. |
| Q36819523 | Semisolid matrix-filled hard gelatin capsules for rapid dissolution of amlodipine besilate: Development and assessment |
| Q43298009 | Silica xerogel-chitosan nano-hybrids for use as drug eluting bone replacement |
| Q39370593 | Silver vanadium oxide and silver vanadium phosphorous oxide dissolution kinetics: a mechanistic study with possible impact on future ICD battery lifetimes. |
| Q35983600 | Silylated precision particles for controlled release of proteins |
| Q33652204 | Simultaneous Optimization of Multiple Response Variables for the Gelatin-chitosan Microcapsules Containing Angelica Essential Oil. |
| Q52649818 | Single Layer Extended Release Two-in-One Guaifenesin Matrix Tablet: Formulation Method, Optimization, Release Kinetics Evaluation and Its Comparison with Mucinex® Using Box-Behnken Design. |
| Q35166232 | Single and dual drug release patterns from shellac wax-lutrol matrix tablets fabricated with fusion and molding techniques. |
| Q90401796 | Single-Dose Pharmacokinetic Properties and Relative Bioavailability of Different Formulations of Posaconazole Oral Suspension in Healthy Volunteers |
| Q41989840 | Sintering of wax for controlling release from pellets |
| Q40497325 | Skin permeation of econazole nitrate formulated in an enhanced hydrophilic multiple emulsion. |
| Q91998473 | Smart Freeze-Dried Bigels for the Prevention of the Sexual Transmission of HIV by Accelerating the Vaginal Release of Tenofovir during Intercourse |
| Q38944396 | Sodium Acetate Coated Tenofovir-Loaded Chitosan Nanoparticles for Improved Physico-Chemical Properties. |
| Q54980860 | Solid dissolution in a fluid solvent is characterized by the interplay of surface area-dependent diffusion and physical fragmentation. |
| Q44672643 | Solid lipid nanoparticles and nanosuspension formulation of Saquinavir: preparation, characterization, pharmacokinetics and biodistribution studies |
| Q40920005 | Solid lipid nanoparticles of a water soluble drug, ciprofloxacin hydrochloride |
| Q36112246 | Solubility Enhancement of Budesonide and Statistical Optimization of Coating Variables for Targeted Drug Delivery |
| Q46093887 | Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets |
| Q42288182 | Solvent Vapor Annealing of Amorphous Carbamazepine Films for Fast Polymorph Screening and Dissolution Alteration. |
| Q92282749 | Spironolactone-Loaded LeciPlexes as Potential Topical Delivery Systems for Female Acne: In Vitro Appraisal and Ex Vivo Skin Permeability Studies |
| Q53670837 | Spray drying formulation of albendazole microspheres by experimental design. In vitro-in vivo studies. |
| Q38764078 | Spray-Dried Thiolated Chitosan-Coated Sodium Alginate Multilayer Microparticles for Vaginal HIV Microbicide Delivery. |
| Q39672710 | Spray-dried doxorubicin-albumin microparticulate systems for treatment of multidrug resistant melanomas |
| Q64239029 | Starch-Based Pickering Emulsions as Platforms for Topical Antibiotic Delivery: In Vitro and In Vivo Studies |
| Q48711097 | Statistical Considerations Concerning Dissimilar Regulatory Requirements for Dissolution Similarity Assessment. The Example of Immediate-Release Dosage Forms |
| Q33803999 | Statistical comparison of dissolution profiles to predict the bioequivalence of extended release formulations |
| Q47990775 | Stearic acid based, systematically designed oral lipid nanoparticles for enhanced brain delivery of dimethyl fumarate |
| Q38802457 | Stimuli-sensitive thiolated hyaluronic acid based nanofibers: synthesis, preclinical safety and in vitro anti-HIV activity. |
| Q37670045 | Strategy for chemotherapeutic delivery using a nanosized porous metal-organic framework with a central composite design |
| Q38417449 | Structural and silver/vanadium ratio effects on silver vanadium phosphorous oxide solution formation kinetics: impact on battery electrochemistry |
| Q58584190 | Structural characterization and pharmaceutical properties of three novel cocrystals of ethenzamide with aliphatic dicarboxylic acids |
| Q57353653 | Studies on Fragrance Delivery from Inorganic Nanocontainers: Encapsulation, Release and Modeling Studies |
| Q34293817 | Studies on formulation development of mucoadhesive sustained release itraconazole tablet using response surface methodology |
| Q46328441 | Study of mesoporous silica/magnetite systems in drug controlled release |
| Q57346669 | Study on glucose release ability from hydroxypropyl cellulose films |
| Q41778603 | Study on sustained-release metformin hydrochloride from matrix tablet: Influence of hydrophilic polymers and in vitro evaluation |
| Q43549760 | Study the effect of formulation variables on drug release from hydrophilic matrix tablets of milnacipran and prediction of in-vivo plasma profile |
| Q39310788 | Submicron Matrices Embedded in a Polymeric Caplet for Extended Intravaginal Delivery of Zidovudine |
| Q37033956 | Supplementation of host response by targeting nitric oxide to the macrophage cytosol is efficacious in the hamster model of visceral leishmaniasis and adds to efficacy of amphotericin B. |
| Q84984889 | Surface responses and desirability functions to determine optimal granulation domains |
| Q90581239 | Sustainable Drug Delivery of Famotidine Using Chitosan-Functionalized Graphene Oxide as Nanocarrier |
| Q57285928 | Sustained Release from Ionic-Gradient Liposomes Significantly Decreases ETIDOCAINE Cytotoxicity |
| Q55508991 | Sustained Release of Green Tea Polyphenols from Liposomal Nanoparticles; Release Kinetics and Mathematical Modelling. |
| Q92948035 | Sustained Release of Vascular Endothelial Growth Factor from Poly(ε-caprolactone-PEG-ε-caprolactone)-b-Poly(l-lactide) Multiblock Copolymer Microspheres |
| Q34700505 | Sustained expression of CYPs and DNA adduct accumulation with continuous exposure to PCB126 and PCB153 through a new delivery method: Polymeric implants |
| Q47613025 | Sustained-release solid dispersion of pelubiprofen using the blended mixture of aminoclay and pH independent polymers: preparation and in vitro/in vivo characterization |
| Q41733173 | Synergistic anti-biofouling effect of Ag-exchanged zeolite and D-Tyrosine on PVC composite against the clinical isolate of Acinetobacter baumannii |
| Q55661041 | Synthesis and Characterization of Lignin Hydrogels for Potential Applications as Drug Eluting Antimicrobial Coatings for Medical Materials. |
| Q38285591 | Synthesis and characterization of folate-targeted dextran/retinoic acid micelles for doxorubicin delivery in acute leukemia. |
| Q92534446 | Synthesis and characterization of mesoporous SBA-15 and SBA-16 as carriers to improve albendazole dissolution rate |
| Q39857728 | Synthesis of (cinnamate-zinc layered hydroxide) intercalation compound for sunscreen application |
| Q40626746 | Synthesis of a novel superdisintegrant by starch derivatization with polysuccinimide and its application for the development of Ondansetron fast dissolving tablet |
| Q38821629 | Synthesis of folate- pegylated polyester nanoparticles encapsulating ixabepilone for targeting folate receptor overexpressing breast cancer cells |
| Q57347913 | Synthesis, evaluation and release studies of NIPA nanopolymers presumed for temperature-controlled drug delivery |
| Q35878744 | Synthetic Zeolites as Controlled-Release Delivery Systems for Anti-Inflammatory Drugs |
| Q89909770 | Tablets of paliperidone using compression-coated technology for controlled ascending release |
| Q57921137 | Tamoxifen citrate loaded biodegradable poly(sebacic acid-co- ricinoleic acid) microparticles, in vitro characterization |
| Q48842562 | Tanshinol sustained-release pellets with absorption enhancer: optimization, characterization, pharmacokinetics and pharmacodynamics |
| Q42588805 | Terminalia gum as a directly compressible excipient for controlled drug delivery |
| Q35567874 | The Design of Nanostructured Metronidazole-Loaded HPC/Oxide Xerogel Composites: Influence of the Formulation Parameters on In Vitro Characterisation. |
| Q38664156 | The Disintegration Process in Microcrystalline Cellulose Based Tablets, Part 1: Influence of Temperature, Porosity and Superdisintegrants. |
| Q49633054 | The Effect of Drug Content Reduction on the In Vitro and In Vivo Properties of Levonorgestrel-Releasing Intravaginal Rings |
| Q93126798 | The Effect of Polydimethylsiloxane-Ethylcellulose Coating Blends on the Surface Characterization and Drug Release of Ciprofloxacin-Loaded Mesoporous Silica |
| Q53671270 | The Influence of Chitosan Cross-linking on the Properties of Alginate Microparticles with Metformin Hydrochloride-In Vitro and In Vivo Evaluation. |
| Q64937369 | The Influence of Differently Shaped Gold Nanoparticles Functionalized with NIPAM-Based Hydrogels on the Release of Cytochrome C. |
| Q50662518 | The Use of Cellulose Membrane to Eliminate Burst Release from Intravaginal Rings. |
| Q44597624 | The ability of retention, drug release and rheological properties of nanogel bioadhesives based on cellulose derivatives |
| Q40963046 | The ameliorated longevity and pharmacokinetics of valsartan released from a gel system of ultradeformable vesicles |
| Q38917202 | The bioactive composite film prepared from bacterial cellulose and modified by hydrolyzed gelatin peptide |
| Q44818556 | The chronic toxicity of ZnO nanoparticles and ZnCl2 to Daphnia magna and the use of different methods to assess nanoparticle aggregation and dissolution. |
| Q51688735 | The development of carbamazepine-succinic acid cocrystal tablet formulations with improved in vitro and in vivo performance. |
| Q41987913 | The effect of acid pH modifiers on the release characteristics of weakly basic drug from hydrophlilic-lipophilic matrices. |
| Q89638246 | The effect of alcohol on ionizing and non-ionizing drug release from hydrophilic, lipophilic and dual matrix tablets |
| Q54033414 | The effect of pH, buffer capacity and ionic strength on quetiapine fumarate release from matrix tablets prepared using two different polymeric blends. |
| Q90086877 | The effect of the source and the concentration of polymers on the release of chlorhexidine from mucoadhesive buccal tablets |
| Q45974645 | The encapsulation and release of guanosine from PEGylated liposomes. |
| Q45741798 | The impact of manufacturing variables on in vitro release of clobetasol 17-propionate from pilot scale cream formulations |
| Q46559881 | The influence of Surelease and sodium alginate on the in-vitro release of tamsulosin hydrochloride in pellet dosage form. |
| Q36129610 | The influence of different long-circulating materials on the pharmacokinetics of liposomal vincristine sulfate |
| Q55401313 | The influence of physical division of tablets on the variability of release kinetics of gliclazide. |
| Q41125434 | The influence of recrystallized caffeine on water-swellable polymethacrylate mucoadhesive buccal films |
| Q41988711 | The influence of the compression force on zidovudine release from matrix tablets. |
| Q31153207 | The influence of thermal treatment and type of insoluble poly(meth)acrylates on dissolution behavior of very soluble drug from hypromellose matrix tablets evaluated by multivariate data analysis |
| Q45736420 | The optimization of an intravaginal ring releasing progesterone using a mathematical model |
| Q28388493 | The role of multiscale computational approaches for rational design of conventional and nanoparticle oral drug delivery systems |
| Q51921835 | Theophylline granule formulation prepared by the wet granulation method: comparison of in vitro dissolution profiles and estimation of in vivo plasma concentrations. |
| Q41967880 | Theophylline-ethylcellulose microparticles: screening of the process and formulation variables for preparation of sustained release particles. |
| Q57489585 | Therapeutically Effective Controlled Release Formulation of Pirfenidone from Nontoxic Biocompatible Carboxymethyl Pullulan-Poly(vinyl alcohol) Interpenetrating Polymer Networks |
| Q46915945 | Thermodynamic Changes Induced by Intermolecular Interaction Between Ibuprofen and Chitosan: Effect on Crystal Habit, Solubility and In Vitro Release Kinetics of Ibuprofen |
| Q42785231 | Thermoreversible mucoadhesive ophthalmic in situ hydrogel: Design and optimization using a combination of polymers |
| Q42004123 | Thermosensitive periodontal sol of ciprofloxacin hydrochloride and serratiopeptidase: Pharmaceutical and mechanical analysis |
| Q53752436 | Thiolated alginate-based multiple layer mucoadhesive films of metformin forintra-pocket local delivery: in vitro characterization and clinical assessment. |
| Q57348588 | Three Ply-Walled Microcapsules for Enhanced Pharmacokinetics of Poorly Absorbed Risedronate Sodium: Novel Stratagem Toward Osteoporosis |
| Q89762328 | Topical Drug Delivery Systems Based on Bacterial Nanocellulose: Accelerated Stability Testing |
| Q53458423 | Triamcinolone acetonide-Eudragit(®) RS100 nanofibers and nanobeads: Morphological and physicochemical characterization. |
| Q92853421 | Tripling the Bioavailability of Rosuvastatin Calcium Through Development and Optimization of an In-Situ Forming Nanovesicular System |
| Q90821702 | Tunable Two-Compartment On-Demand Sustained Drug Release Based on Lipid Gels |
| Q89968151 | Tuning Crystal Structures of Iron-Based Metal-Organic Frameworks for Drug Delivery Applications |
| Q42141840 | Two-step self-assembly of liposome-multidomain peptide nanofiber hydrogel for time-controlled release. |
| Q37727325 | Ultra-flexible nanocarriers for enhanced topical delivery of a highly lipophilic antioxidative molecule for skin cancer chemoprevention |
| Q91990435 | Ultrasound assisted crystallization of a new cardioactive prototype using ionic liquid as solvent |
| Q38643492 | Understanding Drug Release Data through Thermodynamic Analysis |
| Q46260745 | Understanding the anticorrosive protective mechanisms of modified epoxy coatings with improved barrier, active and self-healing functionalities: EIS and spectroscopic techniques |
| Q47749924 | Upgrading of dissolution and anti-hypertensive effect of Carvedilol via two combined approaches: self-emulsification and liquisolid techniques |
| Q39014066 | Uptake and cytotoxicity of docetaxel-loaded hyaluronic acid-grafted oily core nanocapsules in MDA-MB 231 cancer cells. |
| Q37361053 | Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride |
| Q39955527 | Use of propranolol-magnesium aluminium silicate intercalated complexes as drug reservoirs in polymeric matrix tablets |
| Q42599199 | Use of solubility parameter to design dry suspension of cefaclor as a dual pack system. |
| Q89909737 | Validation of kinetic modeling of progesterone release from polymeric membranes |
| Q47115339 | Vapour-phase method in the synthesis of polymer-ibuprofen sodium-silica gel composites |
| Q90953694 | Vascular Endothelial Growth Factor-Releasing Microspheres Based on Poly(ε-Caprolactone-PEG-ε-Caprolactone)-b-Poly(L-Lactide) Multiblock Copolymers Incorporated in a Three-Dimensional Printed Poly(Dimethylsiloxane) Cell Macroencapsulation Device |
| Q92126683 | Vitamin E-Loaded PLA- and PLGA-Based Core-Shell Nanoparticles: Synthesis, Structure Optimization and Controlled Drug Release |
| Q52676913 | Zero-order release of poorly water-soluble drug from polymeric films made via aqueous slurry casting. |
| Q37174993 | pH-Dependent Solubility and Dissolution Behavior of Carvedilol--Case Example of a Weakly Basic BCS Class II Drug. |
| Q91714196 | pH-Sensitive Chitosan-Heparin Nanoparticles for Effective Delivery of Genetic Drugs into Epithelial Cells |
| Q57342180 | pH-sensitive polyelectrolyte films derived from submicron chitosan/Eudragit®L 100-55 complexes: Physicochemical characterization andin vitrodrug release |
| Q64929774 | β-lactoglobulin-irinotecan inclusion complex as a new targeted nanocarrier for colorectal cancer cells. |
Search more.